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RESUMO
Apesar de ser um colonizador da pele e mucosas humanas, a bactéria
Staphylococcus epidermidis tem a capacidade de aderir à superfície de
biomateriais, sendo um dos principais agentes responsáveis pelas infeções
associadas a biofilmes. Bactérias em estado de dormência podem ser
encontradas entre a população metabolicamente heterogénea de um biofilme.
Estas células apresentam baixa atividade metabólica, que tem sido associada à
sobrevivência das bactérias no hospedeiro por longos períodos de tempo, ao
aumento da tolerância aos antibióticos e à evasão ao sistema imune do
hospedeiro. Para estudar a dormência em biofilmes de S. epidermidis, usou-se
um modelo in vitro desenvolvido previamente para variar a proporção de bactérias
dormentes no biofilme. De acordo com este modelo, a acidificação do meio de
cultura causada pelo metabolismo da glucose, é o responsável por induzir a
dormência nas bactérias. No entanto, este efeito pode ser prevenido pela adição
de magnésio ao meio de cultura, durante a formação do biofilme.
Neste trabalho, para caracterizar o estado de dormência em biofilmes de S.
epidermidis foi usada uma análise que integrou múltiplas abordagens. Primeiro,
foi realizada uma análise do transcriptoma total de biofilmes com e sem
dormência. Os dados mostraram que em biofilmes com dormência induzida, a
tradução do mRNA está diminuída, enquanto que houve um aumento da
expressão dos transcriptos envolvidos nos processos de oxidação-redução e no
metabolismo do piruvato. Para determinar a relação entre os transcriptos e as
proteínas de biofilmes dormentes de S. epidermidis, testaram-se diferentes
métodos de extração e correlacionaram-se os dados obtidos. A melhor correlação
(r = 0.37) foi obtida pela combinação da lise mecânica com FastPrep e a solução
de extracção contendo CHAPS. Por fim, foi usada uma metodologia quantitativa
para determinar o proteoma de biofilmes de S. epidermidis com e sem dormência
induzida. De forma similar aos resultados obtidos com a transcriptómica, as
proteínas com atividade catalítica e com atividade GTPase foram encontradas
com expressão aumentada quando a dormência foi induzida, enquanto que
proteínas envolvidas no processo de tradução encontram-se menos expressas.
xNuma tentativa de avaliar a relação entre a dormência no biofilme e o hospedeiro,
determinámos o impacto da dormência em biofilmes de S. epidermidis, analisando
o padrão de reatividade ao soro humano. Curiosamente, a proteína CodY foi
apenas reativa ao soro em biofilmes dormentes, enquanto que a proteína ClpP foi
apenas reativa quando a dormência foi evitada. A expressão da proteína CodY
está aumentada no caso de limitação nutricional uma vez que é sensível à
disponibilidade nutricional. A ausência de ClpP foi previamente associada com a
redução da capacidade para formar biofilmes em S. epidermidis e com virulência
diminuída num modelo animal com infeção por biofilmes desta bactéria. Estes
resultados sugerem que o magnésio poderá ser um fator nutricional importante
nos biofilmes de S. epidermidis.
Por último, foi analisada a relevância da dormência em isolados comensais e
clínicos de S. epidermidis. Vários isolados foram capazes de entrar em
dormência. Contudo, a indução de dormência não pareceu ter afetado de forma
diferente a sobrevivência as células dos biofilmes quando expostas a sangue total
humano. Adicionalmente, foi avaliado o efeito de três antibióticos diferentes contra
biofilmes de S. epidermidis com e sem dormência. A vancomicina não causou
nenhum efeito nos biofilmes formados. Curiosamente, a tetraciclina levou a uma
redução da culturabilidade da bactéria no entanto, não se verificou redução da
viabilidade celular, sendo que teve um maior efeito sobre os biofilmes com
dormência induzida. A rifampicina foi capaz de reduzir a culturabilidade e
viabilidade bacteriana, mas em diferentes escalas. Apesar de a rifampicina causar
morte das bactérias, o desenvolvimento de um estado de viabilidade mas não
cultivável nos biofilmes foi induzido pela tetraciclina e rifampicina.
De forma geral, demonstrou-se que este modelo de dormência caracteriza-se por
um perfil proteómico e transcriptómico próprio, uma interação com o hospedeiro
distinta e com um impacto clínico relevante. No entanto, a caracterização global
da dormência aqui realizada, fornece informação quanto à totalidade do biofilme e
não apenas à subpopulação de bactérias dormentes. Muito provavelmente, as
diferenças entre bactérias cultiváveis e dormentes são maiores que as aqui
referidas.
xi
ABSTRACT
Despite being a common colonizer of human skin and mucosae, Staphylococcus
epidermidis has a strong ability to adhere to biomaterial surfaces. Therefore, S.
epidermidis is among the most common causative agents of biofilm-associated
infections. Dormant bacteria may be found among the metabolically
heterogeneous cells within biofilms. These cells present a low metabolic activity
which has been associated with long-term bacterial survival, increased cellular
tolerance to antibiotics and evasion of the host immune system. To study
dormancy within S. epidermidis biofilms, we used an in vitro model to modulate the
proportions of dormant bacteria within a biofilm. According to this model, the
culture medium acidification, due to glucose metabolism, was responsible for
inducing bacteria into a dormant state. In contrast, this effect was found to be
prevented by the addition of magnesium to the culture medium.
In the present work, an integrative’ omics analysis of dormancy within S.
epidermidis biofilms was used to characterize dormancy state. First, a whole-
transcriptome analysis of biofilms with prevented and induced dormancy was
conducted. The results highlighted that in dormancy, mRNA translation was
decreased, while transcripts involved in oxidation-reduction processes and in the
pyruvate metabolism were upregulated. To determine the relationship between
transcripts and proteins of S. epidermidis biofilms with induced dormancy, different
protein extraction methods were tested and the obtained data was correlated with
the transcriptomic profile. The best correlation was obtained by a combination of
FastPrep mechanical lysis and detergent extraction buffer containing CHAPS. In
this case, the correlation between S. epidermidis biofilms with induced dormancy
mRNA transcripts and protein abundance was 0.37. Then, a quantitative
proteomics approach was used to characterize the whole proteome profile of S.
epidermidis biofilms with prevented and induced dormancy. Similarly to
transcriptome analysis, it was found that expression of proteins involved in
catalytic activity and GTPase activity was overexpressed in induced dormancy.
Additionally, proteins involved in translation processes were found less expressed
in dormancy.
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In an attempt to evaluate the interplay between dormant biofilms and the host, it
was assessed whether dormancy could have an impact on the host immune
reactivity to S. epidermidis biofilms, by analyzing their immunoreactivity pattern to
human sera. Interestingly, CodY protein was only reactive to sera in dormant
biofilms and ClpP protein was only reactive when dormancy was prevented. The
expression of CodY is increased when cells experience nutrient deprivation since
it senses nutrient availability. The ClpP deletion was previously associated with
reduced ability to form S. epidermidis biofilms and with reduced virulence in a rat
model of biofilm-associated infection. These results suggest that magnesium
seems to be an important nutrient in in vitro S. epidermidis biofilms.
Lastly, the clinical impact of dormancy among S. epidermidis isolates was studied.
Curiously, several clinical and commensal isolates were able to trigger dormancy.
However, induced dormancy did not seem to affect differently the survival of
biofilms when exposed to whole human blood. Then, the effect of three different
antibiotics against S. epidermidis biofilms with induced and prevented dormancy
was assessed. Vancomycin did not show any effect on mature biofilms.
Tetracycline led to a reduction of bacteria culturability but not to a reduction of
bacteria viability. Rifampicin was able to decrease bacteria culturability and
viability, but in a different scale. Interestingly, despite rifampicin was also causing
bacteria death, these results point out to the development of a viable but-non
culturable state within biofilms induced by tetracycline and rifampicin.
Overall, using a multiple combined strategy, it was demonstrated that this
dormancy model has a particular transcriptomic and proteomic profile, a distinct
interplay with host and a relevant clinical impact. Importantly, the global
characterization of dormant biofilms here performed, provides information
regarding the whole biofilm and not only about the dormant bacterial cells biofilm
subpopulation. Most probably, differences among culturable and dormant bacteria
are greater than those referenced here.
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1.1. Staphylococcus epidermidis
Staphylococcus epidermidis is a coagulase-negative Gram-positive bacterium,
which colonizes skin and mucosa as a commensal microbe [1]. However, S.
epidermidis may turn into an opportunistic bacterium, being one of the most
frequent causes of nosocomial infections [2-5]. Infections caused by S.
epidermidis are widely associated with a medical device implantation, such as
intravenous catheters [6-9], prosthetic vascular valves [10-14], joint prostheses
[15-17], peritoneal dialysis catheters [18], cardiac pacemakers [19,20],
cerebrospinal fluid shunts [21,22], endotracheal tubes [23], genitourinary tract
catheters [24], intraocular lenses [25,26], breast implants [27-29], and other
polymer and metal implants [30].
The Center for Disease Control and Prevention (CDC) estimates that
approximately half of hospital-acquired infections, in USA, are attributed to
indwelling medical devices [31]. Among them, coagulase-negative Staphylococci
are the leading cause of biomaterials-related infections, with nearly 80% of cases
attributed to S. epidermidis [32]. S. epidermidis is responsible for approximately
30% to 40% of nosocomial bloodstream infections, associated with intravascular
catheter or other prosthetic medical device [30,33]. World Health Organization
official reports are lacking. Nevertheless, it is believed that, in Europe, it is not a
different reality, compared to the USA. For example, in Germany, where more than
2.5 million of medical devices are used annually, it was estimated that up to
100000 patients suffer major complications from their implantation [34]. In
countries such as the UK, France, Italy and Germany, it was estimated that
catheter-related bloodstream infections resulted in 8400 to 14400 episodes of
catheter-related bloodstream infections per year, with 1000 to 1584 deaths in the
same period and an annual burden of 35.9 to 163.9 million euros [35]. In Portugal,
hospital-acquired infections had a 10.6% incidence, in 2012 [36]. These infections
were mainly localized in respiratory airways (29.3%), urinary tract (21.1%), surgery
tissue (18%), and bloodstream (8.1%). Gram-positive bacteria were responsible
for about half of the bloodstream infections (48.4%). Additionally, statistically
significant differences were found when an indwelling medical device was used.
More precisely, the presence of a vascular central catheter increased the number
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of infections to 31.3% (9.7% in absence of catheter vascular central), and urinary
tract device increased the development of an infection to 32.9% (9.7% in absence
of urinary tract device).
Due to the difficulties in obtaining a successful treatment of biomaterials-related
infections caused by S. epidermidis, these infections are associated with a
significant morbidity and expensive costs [37]. Often, the removal of the infected
device is required, affecting patients’ life quality [38]. Additionally, the most
affected patients by S. epidermidis infections are those immunocompromised,
long-term hospitalized and critically ill [2].
1.2. Staphylococcus epidermidis biofilms
Biofilms are defined as “a structured community of cells enclosed in a self-
produced polymeric matrix and adherent to an inert or living surface” [39]. They
can be formed in abiotic and biotic surfaces [40]. S. epidermidis has a strong
ability to adhere to surfaces and to form biofilms, which represents the main S.
epidermidis virulence factor [41].
Consequently, according to the U.S. National Institute of Health (NIH), 80% of the
chronic bacterial infections diagnosed are biofilm-associated (or around 65%
according to the CDC) [42], such as dental caries, periodontitis, cystic fibrosis lung
infection, chronic otitis media, chronic rhinosinusitis, chronic tonsillitis, chronic
wounds, musculoskeletal infections/osteomyelitis, endocarditis, urinary tract
infections and infectious kidney stones/biliary tract infections [43]. The most
prevalent S. epidermidis biofilm-associated infections are bacteremia,
endocarditis, orthopedic prosthetic devices infections, dialysis-catheter associated
infections and genitourinary infections [30].
The extracellular matrix, where biofilm cells are embedded, contributes for a
protected mode of growth that allows survival in a hostile environment [44]. The S.
epidermidis extracellular matrix contains several components which are absolutely
essential for bioﬁlm structure [45,46], such as cell surface and secreted proteins
[47,48], polysaccharides such as poly-N-acetylglucosamine (PNAG, a product of
icaADBC operon [49]) [50], teichoic acids [51], poly-γ-glutamic acid (PGA, a
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product of capBCAD locus) [52] and extracellular DNA (eDNA) [53]. It was shown
that PGA is involved in the protection to antimicrobial peptides (AMPs) and, in the
neutrophil killing and virulence in a mouse model of device-related infection [52].
However, the major exopolysaccharide found in S. epidermidis biofilm matrix is
polysaccharide intercellular adhesin (PIA) or PNAG, responsible for mediating
intercellular adhesion in S. epidermidis biofilm formation and the most important
virulence factor of S. epidermidis biofilms [49,54]. However, even ica negative
strains are able to establish biofilms [55-57] and induce a biofilm infection [57,58].
Therefore, biofilm formation may be mediated by other surface proteins, such as
Bhp [59] and Aap [60]. Also, PNAG has the ability to reduce the activity of AMPs
and the killing by human neutrophils, since phagocytosis and killing by human
polymorphonuclear leucocytes was signiﬁcantly increased in a mutant strain
lacking PIA production in comparison with a wild-type strain [44,61].
Biofilm formation consists in a coordinated sequence of events (Figure 1.1), that
consists on: (a) primary attachment and adhesion of bacteria to a surface; (b)
intercellular aggregation and accumulation of bacteria leading to maturation of the
biofilm; (c) dispersion of single cells or clusters of cells, which may start the whole
process of bioﬁlm formation elsewhere [39,40,62-66].
Figure 1.1.: Biofilm formation stages and the most important components involved in each step.
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After the insertion of an implant, the external surface is rapidly coated with host
proteins, such as fibronectin, fibrinogen, vitronectin, collagen, albumin and
immunoglobulins [67-70]. During the initial attachment/adhesion of bacteria to the
indwelling medical device, several S. epidermidis proteins, known as microbial
surface components recognizing adhesive matrix molecules (MSCRAMMs) [71],
interact with the coated biomaterial [72,73]. MSCRAMMs comprise bacteria
surface adhesion proteins that mediate the attachment to the referred host
proteins anchored onto the biomaterial surface [74]. Consequently, host proteins
coating the biomaterial have been demonstrated to enhance bacterial colonization
[75]. Among the most studied MSCRAMMs are SdrG/Fbe (affinity to fibrinogen)
[76,77], Aae (affinity to vitronectin) [78], AtlE (affinity to vitronectin) [79], Embp
(affinity to fibronectin) [80,81],  and GehD (affinity to collagen) [82]. Other
components were shown to be involved also in the initial steps of biofilm formation,
such as teichoic acids [83] and eDNA [53,84].
The bacterial accumulation/aggregation step is mainly mediated by
exopolysaccharides and proteins which participate in intercellular aggregation of
bacteria, such as PNAG [85], Aap [60], Bhp [59], and also PGA [86]. Finally, the
dispersion of cell clusters from a biofilm contribute to dissemination of the
microorganism extending a biofilm infection and represent an important source of
S. epidermidis infection [87]. The disruption of cell-to-cell interactions within the
biofilm may be due to the phenol-soluble modulins β (PSMβ) [88,89]. PSM are
regulated by agr quorum-sensing system [90,91]. The agr quorum-sensing system
has been implicated in the control of biofilm thickness and biofilm structuring [91],
and it is known to coordinate the communication between bacteria within a biofilm
[92]. In Staphylococcus aureus, the PSM pathogenic activity has been further
studied, with implication in cytolysis, immunomodulation and biofilm development
[93].
Biofilm bacteria are distinct from their free-floating counterparts. More precisely,
biofilm differs from planktonic cells in metabolic activity [94], induced host immune
response [95], transcriptomic expression profile [94,96], protein expression profile
[97], substrate uptake [98], and tolerance to antibiotics [99]. A hallmark of bacterial
biofilms is their higher capacity to tolerate antimicrobial agents in comparison with
planktonic cells [100], revealing the huge clinical impact of this finding. Several
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mechanisms have been enumerated as responsible for tolerance to therapeutics
in infections caused by biofilms, most recently reviewed by Olsen [101]. The
biofilm matrix may limit the penetration and diffusion of some antibiotics [102,103],
despite diffusion through matrix is no longer believed to be a significant factor
[104-106]. Also, antibiotic action may be influenced by different metabolic
physiological states of cells within a biofilm such as in persister cells, other
subpopulations and by slow growth rate [100,102,107-116,116-126]. Additionally,
environmental factors may contribute to antibiotic efficacy, such as oxygen
gradient [127,128], stress response to nutrients limitation, excess of waste
products, low oxygen levels and antimicrobials [123,129-132].
Despite the limitations in using antibiotics against established biofilms, they are
still the main approach to treat biofilm-infections before more drastic procedures,
such as removal of an implanted device. New treatment proposals are being
introduced and tested [133]. However, it is important to develop a strategy that
takes into account the pathogenesis of biomaterial-associated infections, which
depends on the interaction of the bacteria, the device and the host [134].
1.3. The interaction of biofilms with the host immune system
The immune response to S. epidermidis biofilms has been assessed using ex vivo,
in vivo and in vitro models. Cytokine production and expression of cell activation
markers [135-139], phagocytic activity [95,140,141], immunoreactivity [142] and
interaction with whole blood [143,144] were already evaluated in the context of S.
epidermidis infections. However, the knowledge on how the host immune system
interacts and how may be potentiated to eliminate S. epidermidis biofilm infections
is still insufficient.
Biofilm formation can be facilitated by the host inflammatory response since host
inflammatory molecules may facilitate adhesion to the surface of medical devices
[41]. Cardille et al., described that human plasma enhanced S. aureus biofilm
formation, in vitro, leading to an increase of MSCRAMMs expression [145]. Cells
of the human innate immune system also recognize pathogen-associated
molecular patterns (PAMPs) through pattern recognition receptors (PRRs),
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important for the initial bacteria-host contact. Several PAMPs of S. aureus were
already described, such as lipoproteins, peptidoglycan fragments, formylated
peptides and PSM peptides [146]. Interestingly, additionally to PSM role in S.
epidermidis biofilm detachment [89], PSM represent an important
immunomodulator and virulence factor [147]. However, the function of secreted
PSM over immune evasion is not yet known [148].
In S. epidermidis, toll-like receptor 2 (TLR2) and TLR9 seem to be the most
important innate immune recognition receptors of staphylococcal species biofilms,
which recognize lipoteichoic acid [149] and peptidoglycan from staphylococci cell
wall [150]. More specifically, PNAG was reported to stimulate TLR2 [151] and this
was important in clearance of S. epidermidis bacteremia [136]. The potential of S.
epidermidis in activating TLR2 seems to be so strong, that this interaction was
further used to induce expression of antimicrobial peptides in order to enhance a
response to other pathogens [152].
The multilayered and high density structure of biofilms also provides protection to
bacteria against host-defense mechanisms, such as phagocytosis [39,153,154].
Foster [155] and more recently Hanke and Kielian [156] reviewed the host immune
system evasion mechanisms of staphylococci. Despite the lack of information in
how the host immune system interacts and responds to S. epidermidis biofilms,
production of PNAG [95] and formation of a polysaccharide capsule [52] to hide
the bacteria from opsonins and phagocytic immune cells, such as neutrophils and
macrophages [44,140,141,157-162] were enumerated as the main evasion
mechanisms, that result in tolerance to the innate immune response [95,96,154].
Regarding complement system activity against S. epidermidis biofilms, serum C5
factor levels in patients exposed to bioﬁlm forming isolates were higher as
compared to those of patients exposed to non-biofilm forming isolates [144].
Moreover, it was demonstrated that S. epidermidis biofilms activated more
complement factors than planktonic cells, despite C3b and IgG deposition was
lower on bacteria from biofilms, which may contribute to evasion of
polymorphonuclear neutrophils killing [141]. However, opsonization of S.
epidermidis biofilms with IgG and C3b was not required for polymorphonuclear
neutrophils activation [163]. This suggests the existence of other molecules that
can lead to the in vitro activation of polymorphonuclear neutrophils, such as
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proteins [163] and polysaccharides [164] from the S. epidermidis biofilm matrix.
Analysis of the bacteria secreted factors and surface-exposed proteins contribute
to understand the host-pathogen interaction. With that intention, the comparison of
virulent and commensal S. epidermidis strains exoproteome  provided evidences
suggesting that more virulent factors such as hemolysin, antigens and urease,
may contribute to virulence and adaptation of S. epidermidis strains [165].
In addition to phagocytosis, the production of peptides with antimicrobial activity is
an important host innate mechanism to avoid microbial evasion. AMPs are mainly
found in saliva, skin, blood cells, among others. The mode of action of AMPs is
disrupting membrane integrity (via interaction with negatively charged cell
membrane) [166], by inhibiting proteins, DNA and RNA synthesis, or by interacting
with certain intracellular targets, repressing processes such as protein folding, cell
wall synthesis and metabolic turnover [167,168]. However, staphylococci
developed strategies to evade antimicrobial peptides such as surface charge
alterations, extracellular proteases, synthesis of exopolymers and efflux pumps
proteins [169]. Despite the announced disadvantages of using AMPs as treatment
[170], a few were tested against S. epidermidis biofilms, such as human
cathelicidin peptide LL37 which was reported as a potent inhibitor of in vitro bioﬁlm
formation [171], chimeric peptide composed of a dermaseptin derivative, which
prevented in vivo staphylococcal biofilm infections [172], and Ltx peptides that
eliminated metabolic activity in in vitro biofilms [173].
In an attempt to identify potential markers of infection and define possible
therapeutic targets in S. epidermidis biofilm infections, proteomics has been used
to identify immunogens. Therefore, immunoproteomics combines proteomics and
detection of immunoreactive antigens using a biologic fluid [174]. Sellman et al.
identified 29 immunoreactive or serum binding proteins of S. epidermidis using
serum from rabbits previously immunized by intraperitoneal injection [142]. In the
referred work, the authors identified five vaccine candidates, namely acetyl-CoA
C-acetyltransferase, Na+/H+ antiporter, alanine dehydrogenase, lipoate ligase and
cysteine synthase [142]. Later, Pourmand et al. identified autolysin AtlE, lipase
GehD and surface protein ScaB as candidate antigens for prophylaxis or
immunotherapy to control S. epidermidis infection, since they were opsonic in vitro
[175]. However, a similar work using S. epidermidis biofilms was lacking.
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Additionally, differences between in vivo and in vitro biofilms have been
enumerated [176-178]. Despite all of this knowledge, in vivo immune response
against S. epidermidis biofilms may vary according to localization of biofilm
infection, how the foreign device is inoculated and the amount of inoculum [156].
1.4. Heterogeneity of cells within a biofilm
Biofilms are a structurally complex and dynamic system (Figure 1.2).
Figure 1.2.: Staphylococci biofilms. (a) Confocal laser scanning microscopy of S. epidermidis
biofilm (Z = 30µm) stained with LIVE/DEAD [179]; (b) Confocal laser scanning microscopy of S.
epidermidis RP62A biofilms (Z = 24µm) stained with 4’,6-diamidino-2-phenylindole (DAPI) and
wheat germ agglutinin (WGA) [180]; (c) Scanning electron micrograph of S. epidermidis bioﬁlms
[181].
Bacteria physiological state within a biofilm is heterogeneous [182,183] and this
may affect sensitivity to antibiotics and host immune response [184]. Different sub-
populations have been described, such as, growing aerobically, growing
fermentatively, dead and dormant [182] (Figure 1.3).
Figure 1.3.: Physiological heterogeneity within a biofilm.
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Environmental conditions are the main perturbation that can lead to heterogeneity.
Factors such as, concentrations of nutrients (carbon [185,186], nitrogen [187],
phosphate [188], iron-sulfur [189,190], ion sources [191,192]) and the growth
conditions (pH [193,194], temperature [195-200], membrane-acting agents
[110,201],  oxygen availability [131,182,202-204], oxidative stress [131,205-208],
osmotic stress [209-211], and chemical stress [212,213]) are sensed by
microorganisms that adapt to local environment conditions.
Likely, stochastic expression of genes and genetic variations (mutations, genetic
recombination) also generate phenotypic and genetic diversity within biofilms
[214,215]. Consequently, all these factors may influence transcriptionally,
physiologically and morphologically the bacterial cells, in order to adapt and
survive [216].
The structural, chemical and biological heterogeneity within a biofilm seems to
depend on the spatial location of the cells inside the community [215]. Structurally,
cells at the top of Pseudomonas aeruginosa bioﬁlms have increased expression of
genes involved in general metabolic functions, while these genes have decreased
expression in cells at the bottom of the bioﬁlms, suggesting that bacteria in the
upper layer of a biofilm are more metabolically active than those in the lower
layers [114,131]. Dormant sub-population is in a critical physiological state since
most of antimicrobials used in therapeutic require metabolically active cells to be
effective [1,217-221]. In consequence, the presence of dormant bacteria within a
biofilm has been associated with recurrent infections [222,223].
Nowadays, the concepts of cells in viable but non-culturable (VBNC), dormant
(also referred as latent, in Mycobacterium spp. [224,225]), small-colony variant
(SCV) and persister state are very often used to describe a sub-population that
presents tolerance to antimicrobial treatment. However, there is some controversy
in the definition of these terms and they may not have been used properly in all
situations (Figure 1.4).
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In 1944, Joseph Bigger described a small population of Staphylococcus spp. that
persisted to penicillin action [226]. Latter, the concept of persister cells was
improved by Kim Lewis, describing these cells as “dormant variants of regular cells
that form stochastically in microbial populations and are highly tolerant to
antibiotics” that consisted in a small fraction of a bacterial population [221]. More
recently, the definition of persister cells was adjusted by Orman and Brynildsen.
These authors showed that not every persisters are dormant and finished
suggesting that “persistence is far more complex than dormancy” [227], similarly to
what Wakamato et al. described for mycobacteria persisters [228]. These cells are
frequently referred as non-growing dormant cells. In general, persisters are
characterized by: low levels of translation [229,230], lack of protein synthesis to
become tolerant to antibiotics [231] and dowregulation of genes involved in
metabolic and biosynthetic pathways, and energy production [229,232,233].
Importantly, the number of persister bacteria represent about 1% of the cells in the
stationary phase and in biofilm cultures of Escherichia coli [229], but represent a
lower number in an exponential state (about 0.001%) [234,235]. However, the
expression profile of persisters was different from the expression profile of non-
growing stationary phase cells which may suggest a distinct physiological state
[229]. Interestingly, it was observed that inhibition of respiration during stationary
phase reduced persister levels [236]. Curiously, the rate of persister cells
formation was shown to be dependent on the inoculum age [237]. The protocol
that has been widely used to isolate persister cells [235] consists in collecting
bacteria (persisters) by centrifugation, after incubation with high doses of
Figure 1.4.: Terms used to define bacteria that present tolerance to antimicrobial treatment.
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antibiotics. Another protocol was developed using a green fluorescent protein
reporter gene to sort out cells based on the lack of expression of degradable green
fluorescence protein [229]. Interestingly, the degree of persistence was shown to
vary according to the used antibiotic [237,238]. The existence of persister cells
after S. epidermidis biofilms treatment with levofloxacin and vancomycin was also
demonstrated by Shapiro et al., in a higher proportion than in exponential growth
phase [239]. Due to the most recent information on persisters behavior, more and
more researchers defend a new characterization of these cells [227,228,240].
A very close relation between the concept of persister and dormant cells was
announced. It was hypothesized that all persisters are dormant, but not all
dormant cells are persisters [241]. Persisters are referred as the bacteria that grow
after exposure and treatment with high doses of antibiotics, without undergoing
genetic changes [214,235]. However, viability and culturability are different terms
[242]. Dormant bacteria are viable and present low metabolic activity.
Consequently, laboratorial detection of dormant cells may induce misleading
interpretations about the infection status due to absence of growth [243]. In order
to overcome this problem, it is important to assess the number of viable and
culturable cells [138]. The number of culturable cells is easily available by routine
methods, such as counting of colony forming units (CFUs). But CFUs may not
correspond to the real number of viable cells. Thus, fluorescence-based
approaches based on nucleic acids binding and/or exclusion should be employed,
using techniques such as flow cytometry, fluorescence microscopy, and even real
time-PCR experiments targeting 16S rDNA [201,244-246]. As referred above,
dormancy brings implications in therapeutic efficacy and recurrence of biofilm
infections.
Despite the latest improvements, distinction between persisters and VBNC cells is
not yet clear [247-250]. Recent experiments show that VBNC, unlike persisters, do
not form colonies when incubated in enriched medium, but both do not grow under
antibiotic stress [248,251]. Additionally, Orman and Brynildsen assumed that the
main difference between persister and VBNC cells is the ability of persisters to
restart normal growth after antibiotic treatment [251]. Curiously, it was also shown
that VBNCs are more abundant than persisters in untreated antibiotic samples
[249,251]. In a deeper study, it was verified that VBNC and persister cells coexist
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and are induced by the same conditions [249]. VBNC was a concept introduced by
JD Oliver, after Xu et al. publication [252]. VBNC bacteria was defined as “bacteria
metabolically active, while being incapable of undergoing the sustained cellular
division required for growth in or on a medium normally supporting growth of that
cell” [253]. In general, VBNC has been defined as a state where cell is
metabolically active despite their incapacity in forming a colony on a plate [253].
This condition emerged after the underestimation of viable populations of
microorganisms in aquatic environment by culture methods, but detected by
immunofluorescent microscopy, acridine orange direct counting and direct viable
counting [252]. Since then, environmental and food microbiological analysis
became more complex than microorganism culture monitoring, due to the
underestimation of viable cells by CFU counting. This represents a risk to public
health [247] and constitute an important reservoir of pathogens in the environment
[220].
Nevertheless, the VBNC state of bacteria was previously referred as dormancy.
Distinct opinions have been published regarding differences between VBNC and
dormant bacteria. Some authors defend that in VBNC cells, the metabolic activity
is measurable, contrary to dormant cells that have low metabolic activity [254-257].
Others argue that dormant and VBNC are the same cells, since VBNC do not
show metabolic activity [258,259]. Also, Oliver et al. defend that VBNC and
dormant physiological states are the same, presenting low metabolic activity
[249,260]. However, it remains unclear whether VBNCs exhibited significant
metabolic activity and if VBNC and dormant are synonymous. Additionally, it is
defended that VBNC cells may regain culturability, in opposite to Orman et al. data
[251], and are still virulent, capable of causing infection [261-264]. The presence of
VBNC was already observed in S. aureus biofilms subjected to antibiotic pressure
[201]. More precisely, antibiotics and nutrient depletion were used to induce
VBNC, that reduced the culturability of the cultures despite cells were still viable.
Lastly, SCV are defined as slow-growing cells that form smaller colonies on agar
plates (about 10 times smaller than those of normal phenotype) [265], due to
deficiencies in electron transport and in thymidine biosynthesis [266,267]. The
reduced metabolism of SCV [268] and the ability to survive intracellularly
[269,270], also explain the decreased susceptibility to antibiotics. Additionally,
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SCV present a decreased expression of toxins, increased expression of adhesins
and intracellular growth [271]. It was suggested that the SCV phenotype may be a
defense mechanism against environmental stresses [272] and associated with
persistence in the host environment [273]. The existence of SCV in S. epidermidis
biofilms was already demonstrated [274-279].
Despite difficulties to establish correct definitions, the most important consequence
of the existence of VBNC or dormant or persister or SCV cells, is their tolerance to
stress factors and increased tolerance to antibiotics. Consequently, this leads to
bacteria long-term survival in host. In the present thesis, “dormant” and
“dormancy” were the chosen terms to describe the sub-population of cells that are
viable but do not grow in an appropriate solid medium.
1.5. Staphylococcus epidermidis biofilm dormancy model
Previously, Cerca et al. described an in vitro model to induce dormancy in S.
epidermidis biofilms [138] (Figure 1.5).
Figure 1.5.: Model to induce and counteract dormancy in S. epidermidis biofilms.
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In the referred model, modulation of dormant bacteria within S. epidermidis
biofilms was performed by adding divalent ions, such as Calcium (Ca2+) and
Magnesium (Mg2+), to biofilm culture growth in a glucose-enriched medium. The
accumulation of acidic compounds, produced by glucose metabolism, induced
cells to enter in a dormant state, which was counteracted by high extracellular
levels of divalent ions. Acidic pH conditions have the power to inhibit bacterial
growth [280], and Dunne and Burd showed the importance of pH in primary
adhesion of S. epidermidis to surfaces [281]. However, the S. epidermidis ATP
activity at acidic pH showed that this species has the ability to succeed under
acidic pH [282]. Cerca et al. showed that buffering the accumulation of acidic
compounds with hydrogen phosphate to maintain pH conditions prevented the
glucose-dependent accumulation of dormant bacteria [138]. Additionally, a higher
amount of PNAG was found in maintained pH conditions [283]. Those results
proved that the decreased culture pH affected the S. epidermidis biofilms
physiology. The physiological state of S. epidermidis biofilm bacteria was
assessed by staining cells with SYBR Green I and propidium iodide (PI) viability
dyes, using flow cytometry [284], similarly to other works that intended to
determine the number of viable and culturable cells [285-288]. Both PI (red
fluorochrome) and SYBR Green fluorochromes have affinity to DNA, however, PI
only penetrates compromised membranes and displaces SYBR Green due to a
higher affinity [289].
The use of divalent cations to counterbalance the pH effect did not lead to a
decrease of culturable cells, as in S. epidermidis biofilms only grown in glucose
excess [138]. Divalent cations, such as Mg2+ and Ca2+, can bind to teichoic acid
from cell wall [290,291], contributing to maintain the integrity and stability of
bacteria cell wall [292]. However, despite no consensus [293], differences in the
binding affinity of divalent cations to cell wall components of S. epidermidis were
reported [294,295]. Interestingly, Cerca et al., demonstrated that Mg2+ alone
(without Ca2+) could account for preventing the glucose-induced cell dormancy
[296]. Both divalent cations can influence biofilm formation [297] and already in the
1950’s, it was demonstrated that magnesium was needed for bacterial growth
[298,299]. In S. epidermidis biofilms, Mg2+ was shown to increase adhesion and
slime production in biofilm formation [281,300,301]. Also, in Pseudomonas
CHAPTER 1.
Biomedical Sciences PhD 17
fluorescens biofilms, Mg2+ increased initial attachment and altered subsequent
biofilm formation and structure [302]. Later, Mulcahy and Lewenza showed that
magnesium limitation promotes the transition from planktonic to biofilm formation
in P. aeruginosa [303].
Metal ions play an important role in bacteria homeostasis and viability, acting as
co-factors for enzymes, facilitating protein-protein and protein-nucleic acid
interactions and, are involved in membrane stability, stabilizing tertiary structures
of proteins as well as nucleic acids, by regulation of gene transcription, DNA
replication, and protein synthesis [304,305]. The host environment leads to metal
ion fluctuations which contribute for killing of invading pathogens [191]. The mean
serum concentration of Mg2+ in human body is approximately 0.76 to 1.15 mM
[306-308] and is required by DNA and RNA polymerases, as well as many
ATPases and kinases [309]. Thus, the availability of free Mg2+ in the host is
thought to be an important signal for pathogenic bacteria to select in which
compartment they reside [310]. For example, Mg2+ limitation was recognized as an
important environmental trigger to develop P. aeruginosa biofilm [303].
Interestingly, S. epidermidis biofilms that grew without magnesium induced a lower
response of murine immune cells, such as macrophages [138] and dendritic cells
[296], indicating that S. epidermidis with induced dormancy were less inflammatory
than biofilms grown with Mg2+, contributing to evasion of the immune system. It
was shown that production of TNF-α, IL-1 and IL-6 in murine bone-marrow-derived
macrophage cell cultures, as well as that resulting from in vivo macrophage
activation were found decreased when S. epidermidis biofilms grown in the
absence of Mg2+ were used as stimulus [138]. Moreover, although bone marrow-
derived dendritic cells did not significantly alter their surface expression of co-
stimulatory and antigen-presenting molecules upon contact with bacteria from
biofilms with induced dormancy, these induced a lower production of TNF-α, IL-12
and IL-6 upon contact with dendritic cells [296].
Up to now, only MgtE (Mg2+ transporter) and CorA protein (Mg2+channel) were
identified in S. epidermidis as Mg2+ transport proteins. Despite no association to S.
epidermidis virulence, the CorA channel in Salmonella spp. was associated with
virulence [311-313]. A RNA-based metal sensor in bacteria was suggested due to
the regulation of MgtE in response to Mg2+ via M-box riboswitch [314].
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Therefore, differences in growth under different conditions may lead to physiology
changes that may be reflected in a distinct phenotypic proﬁles.
1.6. Proteomic and transcriptomic crosstalk to disclose molecular
pathways in bacterial dormancy
Despite environmental conditions [207,315], a stochastic basis was proposed as a
mechanism of bacterial persisters formation, independent of drug factors (gene
expression affected by cellular, physical and biochemical processes)
[124,230,235,316-318]. Consequently, several genes have been associated to
persistence and dormancy, in an attempt to unravel their molecular genomic
relevant pathways. The analysis of altered expression of genes and proteins can
pinpoint specific pathways in bacterial persistence within biofilms. Different
“omics”, such as genomics, transcriptomics and proteomics, have been employed
in an attempt to characterize dormancy. Together, these approaches give a
distinct coverage of the condition, essential for the elucidation of the molecular
pathways.
Table 1.1 is a compilation of genes, proteins and biological pathways associated
with persistence, dormancy and VBNC. An exhaustive overview of genes, proteins
and biological pathways linked to persisters formation was already performed by
several authors, for different organisms, such as Pseudomonas spp., E. coli and
Mycobacterium spp. [222,319,320]. The most widely studied genes associated
with persisters are the Toxin-Antitoxin (TA) loci, since it was demonstrated that
persister cells contained high levels of TA mRNAs [321] and were involved in
pathogenicity of E. coli and Mycobacterium tuberculosis bacteria [322].
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Table 1.1.: Compilation of genes, proteins and biological pathways associated with persistence,
VBNC, dormancy and resuscitation from dormancy.
Gene/Protein or
Pathway Specie Observation Reference
TCA cycle E. coli
Deletion of TCA cycle enzymes
reduce persister formation in
stationary phase metabolism
[236]
ClpP protease S. aureus Mutation of clpP leads to increasedsusceptibility to antibiotic killing [115]
dinJ
yoeB/yefM E. coli
Genes likely to contribute to
dormancy. However, a knockout of
yoeB had no effect on persister
formation
[229]
dnaK S. aureus Deletion of dnaK produceddecreased number of persisters [323]
oxyR E. coli Prominent gene involved inpersistence to multiple antibiotics [324]
DosP E. coli Phosphodiesterase DosPincreases persistence [325]
GhoT toxin E. coli GhoT increases persistence [326]
glpD E. coli
GlpD is a G3P dehydrogenase
involved in the utilization of glucose
as a carbon source. Its deletion
drastically decreased persister
development
[327]
HipA toxin E. coli hipA7 mutants have increasedrates of persister formation. [328,329]
katG
clpC2
rsbW
sigF
pip
M. tuberculosis Genes upregulated in persisters [233]
Lon protease E. coli Necessary for persister cellformation [330]
MazEF
RelBE
Streptococcus
mutans
Type II toxin-antitoxin systems
caused an increase in the number
of persisters
[331]
MazF E. coli Overexpression of MazF toxin,leads to the formation of persisters [332]
MqsR/MqsA E. coli Overproduction of MqsR toxin isincreased in persistence [333]
NadE M. tuberculosis
NadE was required for persistence
during starvation and under
hypoxic conditions
[334]
Obg E. coliP. aeruginosa
Obg levels control persistence,
mediated by (p)ppGpp [335]
phoU E. coli Deletion of phoU decreases thefrequency of persisters [336]
ppGpp (encoded
by relA and spoT) E. coli
Persisters have high levels of
ppGpp [238,318]
relA E. coli Deletion of relA decreases thefrequency of persisters [337]
relE toxin E. coli Overexpression is increased inpersisters [338]
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relE homologs M. tuberculosis
Ectopic expression of three RelE
homologs also produces drug-
tolerant cells
[339]
rpoS E. coli Involved in the persistence of E.coli in the VBNC state [340]
rpoS
gadB and gadX
mdtF
osmY
E. coli Deletion of these genes increasedpersistence [341]
TA modules
(relBE, mazEF,
dinJ/yafQ,
yefM/yoeB)
E. coli Overexpressed genes in persisters [232]
TisB toxin E. coli Overexpression led to persistersformation [110]
yafQ toxin E. coli May play a role in the formation ofbiofilm persister cells [342]
fba
tsf
tuf
E. coli Genes up-regulated in VBNC [343]
katG Vibriovulniﬁcus
Gene down-regulated in VBNC
under in vitro conditions [344]
tuf
rpoS
relA
Vibrio cholerae Genes down-regulated in VBNC [345]
RMF (Ribosome
Modulation Factor) E. coli
RMF inactivates E. coli ribosomes,
therefore is associated with a
dormant phenotype
[346]
rmf P. aeruginosa
May be required for maintenance
of cell integrity in older dormant
cells, localized at the bottom of the
biofilm
[131]
Rpf (resuscitation-
promoting
factor)
Micrococcus
luteus
Mycobacterium
smegmatis
Rpf was found to stimulate the
growth of dormant cells when
added extracellularly
[259,347]
The first gene to be linked to increased tolerance to antibiotics was hipA gene in E.
coli [328,329] that encodes the toxin part of hipBA TA system. The hipA7 mutant,
decreases the affinity of the toxin to the antitoxin [348], leading to a 1000-fold
increased persister level, as compared to that of the wild type strain, with
increased tolerance toward beta-lactams, ﬂuoroquinolones and aminoglycosides
[232,329]. Later, a greater interest on TA modules/systems occurred due to their
possible link to persisters formation. TA systems consist of a stable toxin, which
inhibits an essential cellular function, and a labile antitoxin, which neutralizes the
activity of its associated toxin [338,349,350]. Under normal conditions, the
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antitoxin establishes a complex with the toxin, inactivating it. However, in stress
conditions, the antitoxin is degraded and the stable toxin is no longer neutralized
[321]. Disregulation of TA systems under stress conditions occurs mainly by
degradation or depletion of the antitoxin by RNAses or Lon protease (ATP-
dependent protease), that may affect DNA replication, translation, peptidoglycan
synthesis, cell division and ATP production, according to the affected TA system
[351]. In case of persistence, studies were mainly developed in E. coli and M.
tuberculosis, showing as main consequence multidrug tolerance [352].
Interestingly, it was shown that in E. coli, the bacteria become dormant if the toxin
level was higher than a threshold, and that the amount by which the threshold was
exceeded determined the duration of dormancy [348]. Additionally, Lon protease is
also required for persistence [330]. When Lon protease was overproduced in E.
coli, persisters levels increased [330], possibly due to the degradation of antitoxin,
the Lon protease target [321].
Until now, five TA systems classes were described, varying in the mode of action
of the antitoxin, involving a broad range of cellular processes [351,353].
Particularly in staphylococcal species, TA modules were already described [354-
358]. SprA1 toxic peptide (PepA1) and the SprA1 RNA antitoxin (type I TA system
that consists on a toxic peptide and an antisense RNA that inhibits toxin translation
[359]) are within a pathogenicity island in S. aureus and induce lytic cell death
[354]. The MazEF TA module (a type II TA system) was described in
Staphylococcus equorum and experiments suggested that in staphylococci, TA
system may also control processes beyond pathogenicity [357]. Also in S. aureus,
MazF toxin was implicated in regulation of staphylococcal virulence factors [356]
and a mazEF orthologue termed pemIK was found in S. aureus plasmid [358].
Lastely, two YoeB homologues of E. coli yefM-yoeB TA system, were found in S.
aureus, with translation initiation inhibitors function [355].
Using Rapid Automated Scan for Toxins and Antitoxins in Bacteria (RASTA-
Bacteria) tool [360], we can predict TA systems in S. epidermidis. Sorted by a
confidence score above 70%, we identiﬁed the following genes in the S.
epidermidis genome (strain RP62A or ATCC 35984 (biofilm-forming) and ATCC
12228 (non-biofilm forming)) (Table 1.2).
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Table 1.2.: Predicted TA systems in S. epidermidis ATCC 35984 and ATCC 12228 by using the
RASTA-Bacteria tool.
Gene Score (%) Possible partners Protein product
ATCC 35984
SERP1550 90.15 SERP1549 andSERP1551 hypothetical protein
SERP1549 89.57 SERP1550 death-on-curing familyprotein
SERP1681 76.34 SERP1682 endoribonuclease MazF
SERP0849 75.34 pgsA cro/ci family transcriptionalregulator
SERP0029 72.59 Rorf_692 cro/ci family transcriptionalregulator
ATCC 12228
SE1672 76.34 SE1673 endoribonuclease MazF
SE0959 75.34 SE0960 hypothetical protein
SE2386 72.59 Rorf_68138 hypothetical protein
Additionally to TA systems, a stringent response may be activated when bacteria
respond to stress, potentiating the transition to a dormant state. In a stringent
response, the alarmone guanosine 5’-diphosphate-3’-diphosphate (ppGpp) and
guanosine 5’-triphosphate-3’-diphosphate (pppGpp), usually referred as (p)ppGpp,
are produced via relA and spoT (which can also degrade ppGpp) during a carbon
and aminoacid limitation [361]. The synthesis of ppGpp reprograms and adjusts
the gene expression of the cells to survive to nutritional limitations [321], having
implications in the DNA replication and proteins synthesis, leading to a decrease
of these processes [361]. Therefore, (p)ppGpp has been implicated in a number of
non-stringent processes, including virulence [361,362], persister cell formation
[238,241] and biofilm formation [363]. (p)ppGpp has been described as an
important persistence mediator and required for persistence [318,321], both in
stochastically and environment-induced persistence [364], since  Korch et al.
reported that E. coli K-12 cells deﬁcient in (p)ppGpp synthesis display a reduced
level of persisters [337]. Additionally, it has been suggested that Lon protease is
required for the ppGpp-dependent persister formation [318]. During starvation, the
high levels of (p)ppGpp destabilize the antitoxin that leads to increased synthesis
rates of both toxin and antitoxin [364].
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When staphylococci undergo a nutrient limitation environment, the activity of
tricarboxylic acid cycle (TCA) increases and the bacteria catabolize non-preferred
carbon sources such as acetate [365]. Under aerobic conditions, S. aureus utilizes
glycolysis, pentose phosphate pathway, and the TCA to catabolize glucose [366].
Under glucose excess there is a high expression of glycolytic enzymes, whereas
expression of TCA enzymes are repressed [367-369]. The repression of TCA
cycle genes is a common response to high concentrations of glucose in culture
media, a response mediated by CcpA in Gram-positive bacteria [65]. Also, several
enzymes involved in TCA cycle require iron, which means that under low iron
availability, TCA cycle activity is reduced [370,371]. Particularly in S. epidermidis,
TCA cycle inactivation leads to an alteration of the metabolic status, resulting in
derepression of PNAG biosynthetic genes [372] .
Clearly, formation of persisters and dormant cells must be linked to a set of
different factors [373]. This phenomenon is not dependent on one or two specific
“persister genes”. Instead, the process is very complex and under multigenic
control. Variation in the expression of a large number of other genes can also
affect persistence or the ability of bacteria to grow in the presence of an
antimicrobial drug. These genes may include global regulators, genes involved in
metabolism, and stress-response components [240].
1.7. Goals
Due to the impact of dormant bacteria in chronic and relapsing infections, it is of
major importance to better understand this physiological state.
Therefore, the main goals of this thesis were to provide a characterization of S.
epidermidis biofilms with induced dormancy by using complementary approaches,
such as:
I. Describing transcriptomic and proteomic profiles of biofilm dormancy;
II. Assessing the correlation of trancriptome and proteome profiles of S.
epidermidis biofilms;
CHAPTER 1.
Biomedical Sciences PhD 24
III. Determining the immunoreactivity profile of biofilm dormancy to
human sera;
IV. Evaluating the clinical relevance of dormancy.
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DORMANCY WITHIN S. EPIDERMIDIS BIOFILMS: A TRANSCRIPTOMIC
ANALYSIS BY RNA-SEQ
Summary
In an attempt to identify the major transcriptomic differences between S.
epidermidis biofilms with prevented and induced dormancy, biological triplicates
from S. epidermidis biofilms were assessed by RNA-sequencing. Significant
differences were found in the expression of 147 genes. A detailed analysis of the
results was performed based on direct and functional gene interactions. Biological
processes among the differentially expressed genes were mainly related to
oxidation-reduction processes and acetyl-CoA metabolic processes. Gene-set
enrichment revealed that the translation process is dependent upon the presence
of dormant bacteria. Transcription of mRNAs involved in oxidation-reduction
processes was associated with induced dormancy within S. epidermidis biofilms.
These results suggest that dormancy within S. epidermidis biofilms lead to a
distinct transcriptomic profile.
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2.1. Introduction
The purpose of this study was to describe the major transcriptomic features of S.
epidermidis biofilms with induced or prevented dormancy, using high-throughput
RNA-sequencing (RNA-seq) technique. RNA-seq has been used for transcriptome
analysis as an alternative to other transcriptomic technologies such as
microarrays, due to advantages such as the large dynamic range, high technical
reproducibility and a reference transcriptome is not a requirement [374-376]. RNA-
seq has been applied to prokaryotic transcriptome studies [377,378] and some
efforts have been made to use next-generation sequencing in clinical microbiology
to test the properties of growing bacterial pathogens [379]. RNA-seq studies in E.
coli and M. tuberculosis dormant persister sub-population have been previously
carried out without biological replicates, being reported that linked to the dormant
state were changes in transcription of genes involved in metabolism, biosynthetic
pathways or oxidative stress [229,233].
To achieve our goal, we performed RNA-seq of three biological triplicates from S.
epidermidis biofilms with prevented and induced dormancy and we used a data
analysis approach based on direct and functional gene interactions analysis,
namely, gene set-enrichment and cluster analysis.
2.2. Materials and Methods
2.2.1. Biofilm growth conditions
S. epidermidis strain 9142 (isolated from blood culture by [380]) was used to
establish biofilms with prevented and induced dormancy, as  previously described
[138]. One colony of strain S. epidermidis 9142 was inoculated in Tryptic Soy
Broth (TSB) (Becton, Dickinson and Company) and incubated at 37 ºC in a shaker
at 120 rpm for 18 h. The overnight culture was adjusted to an optical density at
640 nm of 0.250 (±0.05) with TSB and 10 µL of the suspension was transferred
into a 24-well plate (COSTAR, Corning Incorporated) containing 1 mL of TSB
supplemented with 0.4% glucose (v/v) (TSB 0.4%G) (American Bioanalytical) or
TSB 0.4%G enriched with 20 mM magnesium chloride (MgCl2) (American
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Bioanalytical). The culture plates were then incubated at 37 ºC in a shaker at
120rpm for 24 h. After this period, the culture medium covering the biofilm was
removed and replaced by fresh TSB supplemented with 1% glucose (v/v) (1%G)
or TSB 1%G containing 20 mM MgCl2 (1%G + Mg2+). Biofilms were then allowed
to grow in these same conditions for 24 additional hours. Next, biofilm culture
medium was removed and biofilms were washed twice with 1× phosphate buffered
saline (PBS) (Boston BioProducts). Then, bacteria within the biofilms were
recovered in 1 mL of PBS. All tubes were placed on ice to inhibit cell growth. Prior
to preparation of the RNA-seq library, biofilm dormancy was assessed as
previously described [138]. Briefly, biofilms from both conditions were grown with
the same initial amount of cells. Number of CFU/mL in each condition was
determined using the spread plate method in Trypticase™ Soy Agar with 5%
Sheep Blood (TSA II™) (Becton, Dickinson and Company).
2.2.2. RNA extraction
Total RNA was extracted using the RNeasy Mini kit (Qiagen). To remove genomic
DNA, Ambion® TURBO DNA-free™ kit (Invitrogen) was used followed by acid-
phenol:chloroform precipitation (Ambion), both following the manufacturer’s
instructions. RNA integrity was determined using the Bioanalyzer 2100 (Agilent
Technologies), and samples with RNA Integrity Number (RIN) above 8 were
selected for complementary DNA (cDNA) library preparation. Three independent
biological experiments, each one from a pool of four biofilms, were performed.
2.2.3. cDNA library preparation and Sequencing
Before library preparation, ribosomal RNA (rRNA) was depleted from total RNA
samples using the Ribo-ZeroTM Magnetic kit for Gram-Positive bacteria
(Epicentre), following the manufacturer’s specifications. An Illumina® TruSeq™
RNA Sample Preparation kit (Illumina) was used with the already purified mRNA,
following the manufacturer’s protocol. The construction of the libraries was
rigorously validated by quantitative PCR and Hi-Sensitivity D1K TapeStation
(Agilent 2200 TapeStation). Sequencing data were generated from paired-end
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reads (2 × 150 bp) on a MiSeq® system (Illumina) using a RNA-seq library of 10
nM.
2.2.4. RNA-sequencing data analysis
The removal of sequence adapters, mapping to reference genome and
normalization of gene expression was performed using CLC Genomics
Workbench software (V.5.5.1, CLC Bio.). RNA-seq reads were aligned to the
reference genome of S. epidermidis strain RP62A (Genebank accession number
NC_002976). Gene expression was normalized by calculating Reads per Kilobase
per Million Mapped Reads (RPKM) using the methods described by Mortazavi and
colleagues [381] in which normalization is adjusted by the counts of reads per
kilobase per million mapped and gene length. Since consistency between
experiments is a natural concern in RNA-seq, Pearson correlation was used to
compare RPKM values between triplicates. To test for significant gene expression
changes, Baggerley’s test (beta-binominal) [382] with false discovery rate (FDR)
correction was applied [383]. A p-value ≤ 0.05 was considered statistically
significant. Venn diagram was generated using the Venny tool from BioinfoGP
[384] to identify the transcripts uniquely expressed in each condition.
2.2.5. Biological interactions
Gene Ontology (GO) [385] and KEGG (Kyoto Encyclopedia of Genes and
Genomes) pathways [386] analysis were performed to determine the function of
differentially expressed genes, using STRING database (Search Tool for the
Retrieval of Interacting Genes/Proteins) (version 9.05) [387]. Classes with a p-
value ≤ 0.05 were considered statistically significant. Further analysis was carried
out using Cytoscape software (version 2.8.3) [388], namely a gene-set enrichment
analysis for over- and down-representation in the set of genes with a 1.50 fold-
expression change and their neighbors [389] and a cluster analysis with MCODE
plugin [390]. Biological interpretation was carried out using STRING bioinformatic
tool.
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2.2.6. Quantitative PCR
In order to validate some differentially expressed genes, quantitative PCR (qPCR)
was performed to quantify the mRNA transcripts of pgi, gapA-2, acnA, ureA, ctsR
and rplE. The primers were designed with Primer3 and are shown in Table 2.1.
Table 2.1.: Primers used in qPCR amplification.
Target gene Primer sequence (5’ to 3’) Meltingtemperature (ºC)
Amplicon size
(bp)
acnA FW catattggcctaccggagaa 60 118RV tcacgagaagatcccattcc
pgi
FW tactacgacagaaccagcag 59 170
RV catcaggtacaacaaacgtc
gapA-2
FW agcacctgttgacgttgga 60 171
RV accagttgcaaaagtcctcaat
16S rRNA
FW gggctacacacgtgctacaa 60 176
RV gtacaagacccgggaacgta
ureA
FW gttgtagctgctgaggttgc 59 183
RV agctacgccatccatgacat
ctsR
FW tacaacgcgctcatattgct 60 117
RV cgccaccacgtttactttct
rplE
FW acgtgacttccaaggtgtttc 60 162
RV tcctcgtcagtgttagcagtt
1 µg of total RNA was reverse transcribed using RevertAid First strand cDNA
synthesis (ThermoScientific) using random primers (NZYTech). The experiment
was performed using iQ SYBR 2× green supermix (Bio-Rad) and CFX96™
thermocycler (Bio-Rad) with the following cycling parameters: 10 min at 95 °C
followed by 40 repeats of 5 s at 95 °C, 10 s at 60 °C, and ﬁnally 20 s at 72 °C. The
cycle threshold values (CT) were determined and the relative fold differences were
calculated by the 2(CT reference gene- CT target gene) method [391] using 16S rRNA as the
reference gene. Three independent experiments were run in triplicate. Statistical
significance was analyzed using unpaired t-test (with GraphPad Prism version 6).
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2.3. Results
2.3.1. Transcriptome analysis
We used RNA-seq technology to characterize the transcriptome of S. epidermidis
biofilms with induced and prevented dormancy. Total RNA was isolated from three
biologic replicates of cells within S. epidermidis biofilms grown in excess glucose
with (prevented dormancy) or without Mg2+ (induced dormancy).
Figure 2.1.: Venn diagram summarizing the overlap between genes with RPKM value above 1.00
in S. epidermidis biofilms with prevented (1%G + Mg2+) or induced (1%G) dormancy.
After depletion of rRNA, cDNA libraries were constructed using Illumina®
TruSeq™ RNA Sample Preparation kit and MiSeq® sequencing system. An
average of 3029921 (1%G) and 2650647 (1%G + Mg2+) sequencing reads were
obtained for each cDNA library. A global comparison of genes between biological
triplicates showed a high correlation (r > 0.98, Pearson’s Correlation Coefficient for
induced dormancy and r ≥ 0.95 for prevented dormancy). Prior to trimming the raw
data, a Venn diagram was constructed (Figure 2.1) to summarize the overlap
between genes expressed in each condition.
Figure 2.2.: qPCR validation of some differentially expressed genes. Fold-change expression is
related to S. epidermidis biofilms grown in 1%G plus 20 mM of Mg2+. The bars represent the mean
and the error bars the standard deviation. Statistical significance was analyzed using unpaired t-
test (GraphPad Prism v.6) *p < 0.05, **p < 0.01
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The expressed genes uniquely found in each condition with a RPKM above 1.00
encoded many uncharacterized proteins with unknown functions. Nevertheless,
among identified genes with higher RPKM values only found in S. epidermidis
biofilms with induced dormancy was mazE, a gene which encodes an antitoxin
component of a toxin-antitoxin module (mazEF module) and is related with the
bacterial stress responses through mRNA degradation [392,393].
Figure 2.3.: Significant GO annotation and KEGG pathways of differentially expressed genes (p <
0.05, FDR corrected). Biological processes (a), molecular functions (b), cellular components (c)
and KEGG pathways (d).
For downstream analysis the minimum limit for inclusion of a gene was a RPKM
above 1.00 in both conditions. All genes with RPKM values under 1.00 were
discarded. Thus, among the 2047 genes identified as being transcribed in both
conditions, 147 genes (7%) were differentially expressed between S. epidermidis
biofilms with prevented and induced dormancy, wherein 28 (1%) were up-
regulated and 119 (6%) were down-regulated. Additionally, the distribution of the
log10 RPKM among the differentially expressed genes of each biological triplicate
also showed high agreement between the independent experiments, as
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determined by a r2 value near 1. To further validate our data, qPCR was performed
using a selection of up, or down-regulated genes, as shown in Figure 2.2.
GO annotation was used to classify the functions of the 147 differentially
expressed genes and a biological pathway-based analysis was performed using
the KEGG pathway. All statistically significant categories are represented in Figure
2.3, including the oxidation-reduction and acetyl-CoA metabolic biological
processes (Figure 2.3a), oxido-reductase functions and ribosome activity as the
main molecular functions (Figure 2.3b). Cytoplasm and intracellular components
were the main cellular components represented in the differently expressed genes
(Figure 2.3c). The enriched KEGG pathways were for the ribosome synthesis
pathway and pyruvate metabolism (Figure 2.3d).
In order to provide a more detailed analysis through pyruvate pathway, KEGG
metabolic network was consulted and pyruvate cycle scheme was drawn to
identify which enzymes involved in this pathway are encoded by differentially
expressed genes (Figure 2.4).
Figure 2.4.: Scheme of pyruvate metabolism and related products including genes which encode
enzymes in each specific reaction. Red circles represent enzymes encoded by differentially
expressed down-regulated genes in S. epidermidis biofilms with prevented dormancy.
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Relevant biological processes and
KEGG pathways within differentially
expressed genes on replicates are
shown in a heat map (Figure 2.5),
constructed to depict fold-change
values, by using Matrix2png [394].
Gene expression showed down-
regulation of oxidation-reduction
process, pyruvate metabolism and
acetyl-CoA metabolic process in S.
epidermidis biofilm with prevented
dormancy compared to biofilms
with induced dormancy.
Conversely, pathways involved
with ribosomes were up-regulated
in biofilms with prevented
dormancy. Twenty eight of the
differentially expressed genes
encoded uncharacterized proteins
with unknown functions. In an
attempt to find homology with
known proteins, we performed a
BLAST analysis, a search in the
Pfam database (version 27.0) for
Pfam domains [395] and PSORTb
program (v. 3.0) [396] to predict
their sub-cellular localization
(Table 2.2). Despite BLAST
analysis indicate some homology
with genes encoding
uncharacterized proteins from
other species, most of the
translated proteins would have a cytoplasm or cytoplasmic membrane localization,
whereas 15 other proteins contained annotated domains in the Pfam database
Figure 2.5.: Heat map of main biological processes
and KEGG pathways statistical significant in
differentially expressed genes between induced and
prevented dormancy of S. epidermidis biofilms.
Values represent fold-change expression among
biological triplicates. Red and green colors
correspond to decrease and increase expression,
respectively. Heat map was constructed using
Matrix2png.
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indicating these were primarily domains with unknown functions. Table 2.3 lists the
10 most highly transcribed genes based on RPKM values from S. epidermidis
biofilms with prevented dormancy.
Table 2.2.: Differentially expressed genes representing uncharacterized proteins with significant
Pfam domain, including predicted localization by PSORTb.
Name Function Predictedlocalization
Protein family (Pfam) domain
match
serp0087 Uncharacterized protein Cytoplasm Uncharacterized conservedprotein
serp0121 Uncharacterized protein Unknown Protein of unknown function
serp0581 UPF0413 protein Cytoplasm Thioredoxin
serp0701 UPF0358 protein Unknown Protein of unknown function
serp0707 Uncharacterized protein Cytoplasmicmembrane Protein of unknown function
serp0741
Uncharacterized N-
acetyltransferase Cytoplasm
Acetyltransferase (GNAT)
domain
serp1053 Uncharacterized protein Cytoplasmicmembrane Protein of unknown function
serp1180
Putative Holliday junction
resolvasea Unknown Uncharacterized protein family
serp1210 Uncharacterized protein Cytoplasm Protein of unknown function
serp1402 Uncharacterized protein Cytoplasmicmembrane
Bacterial protein of unknown
function
serp1720 UPF0340 protein Cytoplasm Protein of unknown function
serp1754 Uncharacterized protein Cytoplasm NADH(P)-binding
serp1771 Uncharacterized protein Cytoplasmicmembrane
Domain of unknown function:
Predicted membrane-bound
metal-dependent hydrolase
serp1783 Uncharacterized protein Cytoplasmicmembrane
Domain of unknown function:
Small integral membrane protein
serp2066 Uncharacterized protein Cytoplasm
Domain of unknown function:
Uncharacterized protein
conserved in bacteria
a Could be a nuclease that resolves Holliday junction intermediates in genetic recombination
Among the down-regulated and up-regulated transcripts in these S. epidermidis
biofilms were genes mostly associated with oxidation-reduction and metabolic
processes, respectively. Interestingly, most of the differentially expressed genes
had a relatively small fold-change (-5.60 to 2.92), of which 13 of the up-regulated
genes had a fold-change above 1.50 and 80 genes had a fold-change under -1.50.
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Figure 2.6 shows RPKM values of a few S. epidermidis virulence genes [1] among
the two distinct conditions.
Table 2.3.: List of 10 genes with higher RPKM values, among the differentially expressed genes, in
S. epidermidis biofilms with prevented and induced dormancy. Only genes with a fold-change
expression ≤ -1.50 or ≥ 1.50 were included. All genes had a FDR-corrected *p < 0.05
Gene Definition RPKM1%G
RPKM
1%G +
Mg2+
Fold-
change
Rank down-regulated
1 serp1782 Alkaline shock protein 23 18172.55 7034.27 -2.58
2 serp0244 Aldo/keto reductase 5885.19 2759.36 -2.13
3 pdhD Dihydrolipoamidedehydrogenase 4352.90 2433.65 -1.79
4 pdhA
Pyruvate dehydrogenase
complex E1 component,
alpha subunit
3908.68 2361.75 -1.65
5 recA Recombinase A 4788.63 1654.38 -2.89
6 serp1784 Uncharacterized protein 4967.70 1624.00 -3.06
7 mqo-4 Malate:quinoneoxidoreductase 3457.27 1590.09 -2.17
8 lexA LexA repressor 3307.97 1571.21 -2.11
9 aldA-2 Aldehyde dehydrogenase 3645.71 1569.85 -2.32
10 ptsI Phosphoenolpyruvate-proteinphosphotransferase 2156.90 1350.52 -1.60
Rank up-regulated
1 serp0419 Ribosomal subunit interfaceprotein 4191.31 12241.98 2.92
2 ctsR CtsR family transcriptionalregulator 2279.57 6328.79 2.78
3 serp0163 UvrB/UvrC domain-containing protein 1885.05 4870.32 2.58
4 serp0164 ATP:guanidophosphotransferase 1775.17 4289.27 2.42
5 ppaC Manganese-dependentinorganic pyrophosphatase 443.67 861.75 1.94
6 rpsM 30S ribosomal protein S13 425.78 698.09 1.64
7 serp1180 Putative Holliday junctionresolvase 368.63 583.88 1.58
8 rplE 50S ribosomal protein L5 279.81 505.85 1.81
9 ureA Urease subunit gamma 182.26 473.11 2.60
10 rpsQ 30S ribosomal protein S17 225.01 456.69 2.03
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Figure 2.6.: Variation of log2(RPKM) among some known virulence genes in S. epidermidis
biofilms with prevented (1%G + Mg2+) and induced (1%G) dormancy. The bars represent the mean
and the error bars the standard error of the mean.
Although differences were not statistically significant, in general, virulence genes
seemed to be slightly more transcribed in prevented dormancy.
2.3.2. Enrichment map analysis and cluster analysis
Downstream analysis of transcripts was based in direct and functional gene
interactions with Cytoscape [397]. STRING was used to create a gene interaction
network including all differentially expressed genes and neighbors, yielding a total
of 1442 nodes and 10295 edges. The GO analysis from the gene set-enrichment
is given in Table 2.4. Enrichment map analysis of the up-regulated and neighbor
genes associated with S. epidermidis biofilms with prevented dormancy revealed
distinct functions involved in translation and biosynthetic processes, such as
macromolecular synthesis. Conversely, down-regulated genes encoded catabolic
processes and oxidoreductase activity. Gene clusters were obtained in Cytoscape
with MCODE plugin. Among the differently expressed genes we found 2 gene
clusters with a score value above 2.0 and at least 4 nodes (Figure 2.7). The main
biological processes of each cluster were in accordance with the results obtained
in the gene set-enrichment.
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Table 2.4.: Statistically significant biological processes from gene set-enrichment analysis.
Gene-set
enrichment Biological process p-value *
Up-regulation
GO:0006412 Translation 4.56E-15
GO:0044267 Cellular protein metabolic process 2.52E-10
GO:0010467 Gene expression 3.75E-09
GO:0034645 Cellular macromolecule biosynthetic process 4.68E-09
GO:0019538 Protein metabolic process 8.31E-09
GO:0009059 Macromolecule biosynthetic process 8.58E-09
GO:0044249 Cellular biosynthetic process 2.89E-05
GO:0015986 ATP synthesis coupled proton transport 7.83E-05
GO:0009058 Biosynthetic process 1.84E-04
GO:0006754 ATP biosynthetic process 5.53E-04
GO:0044260 Cellular macromolecule metabolic process 1.07E-03
GO:0043170 Macromolecule metabolic process 4.97E-03
GO:0009142 Nucleoside triphosphate biosynthetic process 1.14E-02
GO:0034220 Ion transmembrane transport 1.14E-02
GO:0015992 Proton transport 2.65E-02
Down-regulation
GO:0008152 Metabolic process 9.76E-04
GO:0055114 Oxidation-reduction process 1.44E-03
GO:0006006 Glucose metabolic process 2.16E-02
* Bonferroni correction
Figure 2.7.: Clusters generated by MCODE plug-in in Cytoscape, including fold-change
expression. Red, green and yellow circles represent fold-change values under -1.50, above 1.50
and, between -1.50 and 1.50, respectively. Biological processes are translation and biosynthetic
processes (a); and tricarboxylic acid cycle, acetyl-CoA catabolic process, coenzyme catabolic
process, cofactor catabolic process, acetyl-CoA metabolic process, aerobic respiration, cellular
respiration, energy derivation by oxidation of organic compounds, coenzyme metabolic processes
(b)
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2.4. Discussion
It has been reported that cells in the deeper layers of the biofilms are less active
than the ones in the upper layers, although they are still viable but with a slow
growth and a low metabolic rate [131,217]. Bacterial phenotypes can change
according to environmental conditions and chemical-concentration gradients,
generating distinct populations and contributing to heterogeneity within biofilms
[215]. Dormancy is considered an adaptive response to adverse environmental
conditions. Since the survival capacity of dormant bacteria in biofilm-related
infections is increased [217], it is of utmost importance to characterize S.
epidermidis biofilms dormant sub-population. In order to improve mRNA
quantitation by RNA-seq technology, many transcriptomic studies have tried to
increase the information content by depleting rRNA [398]. Previous bacterial RNA-
seq studies suggest that a minimum of 2–5 million reads from an rRNA-depleted
library are required for accurate coverage [398]. Moreover, paired-end sequencing
is a more efficient strategy to characterize and quantify the transcriptome of
bacteria without annotated genomes [399]. Besides biological variability, technical
issues like coverage [378], sequence depth [400], variation from one flow cell to
another [399], variation between the individual lanes within a flow cell [399] and
library preparation effect [401] may also affect sequencing and cause variability
within replicates. In order to overcome these limitations, we ran 3 biological
replicates consisting of pools of 4 biofilms for each replicate in order to obtain
more accurate results. This approach contributed to the observed consistency in
our data.
GO analysis has been used in genome-wide expression studies to reduce
complexity and highlight biological processes [402]. GO analysis of the 147
differentially expressed genes between the two studied conditions identified
ribosome activity, oxidation-reduction and acetyl-CoA metabolic processes as the
major classes with differences in mRNA transcripts comparing biofilms with
induced and prevented dormancy. The main biological processes and KEGG
pathways showed consistency within gene expression levels among biological
triplicates and evidence that genes involved in oxidation-reduction, acetyl-CoA
metabolic processes and pyruvate metabolism were less expressed in biofilms
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with prevented dormancy as opposed to when their development did not include
addition of Mg2+ to the culture medium. In the opposite, ribosome pathway was
more expressed in S. epidermidis biofilms with prevented dormancy. Differentially
expressed genes encoded transcripts mostly localized to the intracellular
compartments, suggesting that the major changes related to the development of
dormancy are occurring within the cell cytoplasm. These results were expected
since S. epidermidis biofilms grown in the presence of Mg2+ have a lower number
of dormant bacteria and consequently more metabolically active cells. In addition,
half of the most down-regulated gene transcripts in prevented dormancy are
involved in oxido-reductase activity, such as serp0244, pdhA, pdhD, aldA and
mqo3 (Table 2.3). Conversely, the most up-regulated genes are mainly related to
metabolic processes. Previously, the impact of virulence of dormant S. epidermidis
biofilm was demonstrated using in vitro and in vivo models [138,296]. In the
present work, biofilms with prevented dormancy had an increased, but not
significant, expression of some of the main virulence genes.
Glucose has a key role in biofilm physiology [96,380]. The major pathways for
glucose catabolism in Staphylococci are glycolysis, the pentose-phosphate
pathways and the TCA cycle [366]. Recently, it was proposed a metabolic-based
strategy to target and eradicate bacterial persisters. Allison et al. showed that
carbon source metabolites (such as glucose, mannitol and fructose) may be used
to generate proton motive forces, potentiating the aminoglycosides activity against
persister cells [403]. Similarly, Peng et al. showed the use of exogenous glucose
and alanine to stimulate the central metabolic pathways and therefore increase the
uptake of antibiotic through resistant bacteria [404]. Not surprisingly, glucose has
influence in biofilm physiology since glucose metabolism leads to accumulation of
acidic products decreasing the pH of the culture medium [405]. The model that we
previously described showed that dormancy was a consequence of excess of
glucose catabolism that lead to the acidification of the culture medium and
consequently to the accumulation of dormant bacteria within S. epidermidis biofilm
[138]. This phenomenon was prevented by the presence of high extracellular
levels of magnesium which did not change the pH of the culture medium,
indicating that the Mg2+ effect on preventing cell dormancy was not related to the
pH of the culture, since low pH was still maintained in the presence of Mg2+ [406].
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Low pH was previously associated with a loss of activity of glycolytic enzymes and
damage to cell membrane and macromolecules such as proteins and DNA, and
was related to changes in biogenesis and maintenance of cell membrane integrity
[407]. Additionally, it was shown that pH-mediated potentiation of aminoglycosides
is effective against both in vitro and in vivo Gram-positive of nosocomial
pathogens [408].
Piddington et al. demonstrated that Mg2+ is essential to M. tuberculosis growth in
acidic conditions and it could not be replaced by other divalent cations [409]. A
possible influence of Mg2+ in protein structure and physical properties was also
described in M. tuberculosis [410]. Interestingly, Mg2+ levels in biofilm cultures
were maintained over time [406]. In addition, genes related to the Mg2+ transport
system, such as corA, mgtE and serp1967 [411] were not differentially expressed,
suggesting that high Mg2+ levels culture are also not stimulating expression of
magnesium transport genes.
Previous work with dormant bacterial cultures demonstrated decreased levels of
macromolecule synthesis, nutrient transport and respiration rates [260]. Moreover,
earlier transcriptomic studies of dormant persister cells of several microorganisms
showed a down-regulation of energy and metabolism pathways [233], increased
reactive oxygen species levels [412] and down-regulation of genes involved in
energy production [229]. Toxin overexpression from toxin-antitoxin modules has
been linked to the persister fraction in E. coli and M. tuberculosis cultures [413].
The toxin-antitoxin module mazEF is highly conserved in Staphylococcus species
and was described in detail in S. aureus, where antitoxin MazE binds toxin MazF
to neutralize ribonucleases activity [414]. Despite no alterations in mazF
expression between S. epidermidis biofilms grown in the absence or presence of
Mg2+, the mazE gene had a RPKM superior to 1.00 in dormant biofilms.
Taken together, these results reveal that transcription of genes involved in
oxidation-reduction processes and glucose metabolism, including the acetyl-CoA
and pyruvate pathways, was more active in dormant S. epidermidis biofilms,
despite no differences in glucose consumption, probably due to lower metabolism
of dormant bacteria. On the other hand, genes related to ribosome activity were
up-regulated in S. epidermidis biofilms when Mg2+ levels were higher in the growth
medium. Additionally, these results provide evidence that the genes directly
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involved in Mg2+ transport do not seem to have a direct role in the shift to
dormancy. The global changes found in this work do not provide information
concerning gene expression confined only to the dormant bacterial cells. Most
probably, differences among culturable and dormant bacterial cells are greater
than those referenced here. Single-cell analysis methods are being developed and
may allow a more accurate comparison between these physiological states [415].
Yet, dormant bacterial cell isolation is still a meaningful challenge.
Overall, these results contribute to a better understanding of the mechanisms
underlying the dormancy phenomena. Nevertheless, these findings also raise
questions regarding the role of dormant S. epidermidis biofilms in virulence, since
it is still debatable if there is a lower virulence potential due to lower metabolism or
if expression of a specific gene or a set of genes could lead to the suppression of
the host immune response.
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COMPARATIVE PROTEOMIC AND TRANSCRIPTOMIC PROFILE OF S.
EPIDERMIDIS BIOFILMS GROWN IN GLUCOSE-ENRICHED MEDIUM
Summary
Contrary to some advances made in the transcriptomic field, proteome
characterization of S. epidermidis biofilms is less developed. To highlight the
relation between transcripts and proteins of S. epidermidis biofilms, we analyzed
the proteomic profile obtained by two mechanical lysis methods (sonication and
bead beating), associated with two distinct detergent extraction buffers, namely
SDS and CHAPS. Based on gel electrophoresis-LC-MS/MS, we identified a total
of 453 proteins. While lysis with glass beads provided greater amounts of protein,
CHAPS extraction buffer allowed identification of a higher number of proteins
compared to SDS. Our data shows the impact of different protein isolation
methods in the characterization of the S. epidermidis biofilm proteome.
Furthermore, the correlation between proteomic and transcriptomic profiles was
evaluated. The results confirmed that proteomic and transcriptomic data should be
analyzed simultaneously in order to have a comprehensive understanding of a
specific microbiological condition.
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3.1. Introduction
The availability of the complete genome of S. epidermidis strains RP62A (ATCC
35984) [411] and ATCC 12228 [416] has led to the development of proteomic
studies, since it has been suggested that the genome sequence is not sufficient to
elucidate the biological functions of an organism [417]. Although there have been
major advances in the molecular characterization of the pathogenic mechanisms
of S. epidermidis biofilms [1], much less is known regarding the proteome. A few
proteomic studies, however, have been performed in order to identify specific
features associated with the pathogenicity and physiology [418-421]. In S.
epidermidis, 2-Dimensional Electrophoresis (2-DE) analysis of proteomic patterns
showed several differentially expressed proteins when comparing commensal and
invasive strains [418]. To ensure high quality and reliable proteomic results, an
appropriate sample preparation is fundamental [422,423]. Due to the complex
structure of biofilms [46], it is necessary to develop an effective lysis method in
order to obtain maximum coverage of the biofilm proteome and minimal protein
losses, similar to the approach optimized for total RNA extraction from S.
epidermidis biofilms [424]. Different protein extraction methods, including
enzymatic, chemical, mechanical and other methods available via commercial
extraction kits have been tested to obtain the highest number of proteins in
Staphylococcus spp. [97,425]. Although the majority of these studies were
performed with cell suspensions, relatively harsh techniques have been shown to
be rapid and efficient to disrupt and lyse biofilms of Gram-positive bacteria, such
as mechanical methods like bead beating with glass beads (FastPrep) or
sonication [97,426,427]. Often, to optimize protein recovery, enzymes and
detergents may be used in conjugation with mechanical lysis. Since lysostaphin
efficiently cleaves staphylococcal cell wall peptidoglycan [428,429], it may be used
to disrupt staphylococcal biofilms [430]. However, due to high costs of lysostaphin,
detergents are frequently used  to enhance protein isolation and solubilisation
[431].
In an attempt to determine the relation between protein and mRNA levels, several
studies have shown that often the correlation is surprisingly low, and differs widely
among organisms [432]. Correlation coefficients were found to vary from 0.09 to
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0.46 in multi-cellular organisms, from 0.34 to 0.87 in yeasts, whereas in bacteria
the correlations ranged from 0.20 to 0.47 [433]. Up to now, no correlation analysis
between the transcriptome and proteome of S. epidermidis biofilms has been
conducted.
Hence, herein, since distinct lysis and extraction methods may yield different
protein recoveries, we assessed different lysis methods to obtain proteins from S.
epidermidis biofilms grown in glucose-enriched medium. Then, we compared the
proteomic profile with the gene expression profile obtained by RNA-seq
technology. We undertook a gel-based method to determine protein isolation
efficiency, using total protein extracted with a detergent-based extraction (SDS
(sodium dodecyl sulfate) or CHAPS ((3-((3-cholamidopropyl) dimethylammonio)-1-
propanesulfonate))) coupled with mechanical lysis (sonication or bead beating). A
detailed analysis of proteomic data was performed in each condition. Label-free
relative protein abundance, determined by exponentially modified protein
abundance index (emPAI) was used for the relative quantitation of the proteome
and was compared to transcriptomic profile. The overall goal was to characterize
and correlate both proteomic and transcriptomic profiles of S. epidermidis biofilm-
grown cells.
3.2.Materials and methods
3.2.1. Growth conditions
Biofilm forming S. epidermidis strain 9142 was used as a model [380]. One colony
was inoculated into 1 mL of TSB (Liofilchem) and incubated at 37 ºC at 120 rpm
for 18 h. The overnight culture was adjusted to an optical density at 640 nm of
0.250 (±0.05) with TSB and 10 µL of the suspension was transferred into a 24-well
plate (Thermo Fisher Scientific) containing 1 mL of TSB supplemented with 0.4%
glucose (v/v) (Thermo Fisher Scientific). The culture plate was then incubated at
37 ºC at 120 rpm for 24 h. After this period, the culture medium covering the
biofilm was removed and replaced by fresh TSB supplemented with 1% glucose
(v/v). Biofilms were allowed to grow in these same conditions for 24 additional
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hours. Thereafter, biofilm culture medium was removed and biofilms were washed
twice with PBS.
3.2.2. Protein preparation
The same number of biofilms (twelve biofilms for each condition) were directly
scraped and suspended in detergent extraction buffers: 25 mM Tris-HCl (pH = 7.2)
(Pharmacia Biotech), 10 mM CHAPS (Sigma-Aldrich), 0.5 M NaCl (VWR), 5%
glycerol (Sigma-Aldrich) and 1 mM PMSF (Sigma-Aldrich) or 60 mM Tris-HCl (pH
= 6.8), 10% glycerol, 5% SDS (USB Corporation) and 1 mM PMSF. Mechanical
lyses was performed in a sonicator (Cole-Parmer® 750-Watt Ultrasonic
Homogenizer, Cole Parmer) (10 min, 30 s running, 10 s pause, 40% amplitude) or
by bead beating, using glass beads of 0.1 mm (Sigma-Aldrich) in a FastPrep® cell
disruptor (BIO 101, ThermoElectron Corporation, Thermo Fisher Scientific) (3
cycles of 30 s and 6.5 m/s). After lyses, cell debris were removed by centrifugation
(15,000 g for 15 min at 4 ºC) and proteins precipitated with cold acetone [434].
Then, protein quantification was performed using the RC-DC assay (Bio-Rad),
following the manufacturer’s instructions.
3.2.3. One-dimensional gel electrophoresis (SDS-PAGE) in gel protein
digestion and protein identification
Forty µg of protein were incubated with SDS 10% (w/v), 0.5 M Tris-HCl (pH 6.8),
glycerol, mercaptoethanol and bromophenol blue (w/v) for 5 min at 100 ºC. Then,
samples were loaded on Novex NuPAGE® 4-12% Bis-Tris gel (Life Tecnologies)
and proteins were separated at a constant voltage (200 V). The gel was stained
with colloidal Coomassie G-250 and all the lanes were manually excised into 16
gel slices for in-gel digestion with trypsin TPCK (AB Sciex). Peptide extraction was
made with 10% formic acid/ 50% acetonitrile. Dried peptides were dissolved in 5%
acetonitrile (ACN) (VWR), 0.1% formic acid (Sigma-Aldrich) and 0.1%
trifluoroacetic acid (TFA) (Sigma-Aldrich). Separation of tryptic peptides by nano-
HPLC was performed on the module separation Ultimate 3000 (Dionex, Thermo
Fisher Scientific) using a capillary column (Pepmap100 C18; 3 µm particle size,
0.75 µm internal diameter, 15 cm in length). A gradient of solvent A,
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(water/ACN/TFA (98:2:0.05, v/v/v)) to solvent B (water/ACN/TFA (10:90:0.045,
v/v/v)) was used. The separation of 2 µg/µL sample was performed using a linear
gradient (5-50% B for 30 min, 50-70% B for 10 min and 70-5% A for 5 min) with a
flow rate of 0.3 µL/min. The eluted peptides were mixed with a continuous flow of
α-cyano-4-hydroxycinnamic acid (αCHCA) matrix solution (270 nL/min, 2 mg/mL in
70% ACN/0.1% TFA and internal standard Glu-Fib at 15 ftmol) and applied directly
on a MALDI plate in 20 s fractions using an automatic fraction collector Probot
(Dionex, Thermo Fisher Scientific). Mass spectra were obtained on a matrix
assisted laser desorption/ionization–time of flight MALDI-TOF/TOF mass
spectrometer (4800 Proteomics Analyzer, Applied Biosystems) in the positive ion
reflector mode and obtained over the mass range from 700-4500 Da with 900
laser shots. A fragmentation voltage of 2 kV was used throughout the automated
runs. The spectra were processed and analyzed by the T2S (v1.0, Matrix Science
Ltd.) and submitted in Mascot software (v.2.3.0.2, Matrix Science Ltd.) for
protein/peptide identification based on MS/MS data using the following criteria:
trypsin as enzyme; a maximum of two missed cleavages; mass tolerances of 40
ppm for peptide precursors, mass tolerance of 0.6 Da was set for fragment ions.
Simultaneously, phosphorylation of Threonine (T), Serine (S) and Tyrosine (Y)
were searched as variable modifications. The local FDR was calculated by
searching the spectra against SwissProt (Firmicutes, release date 06.02.2013)
decoy (random) database. Protein identification was considered reliable when the
individual ion score for each peptide had a minimum individual score of 95% and a
minimum sequence tag of four aminoacids. Relative quantitation was determined
by emPAI. Gene ontology [385] analysis was performed with proteins identified in
each extraction condition using STRING database (version 9.1) [387] (statistically
significant specific GO terms, FDR-adjust p < 0.05). Two independent experiments
were performed with pools of S. epidermidis biofilms.
3.2.4. RNA sequencing
RNA extraction from S. epidermidis biofilms, cDNA library preparation and RNA-
seq, were performed as described in Chapter 2. Gene expression was normalized
by calculating RPKM using the methods described by Mortazavi and colleagues
[381], in which normalization is adjusted by the counts of reads per kilobase per
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million mapped and gene length. All genes with RPKM value under 1.00 were not
considered for analysis. Three independent experiments, each one from a pool of
four biofilms, were performed.
3.3. Results and Discussion
3.3.1. Proteomic characterization
In the present study, a proteomic and a transcriptomic analysis of S. epidermidis
biofilms grown in glucose-enriched medium was performed using gel-based
proteomic separation and LC-MS/MS analysis along with RNA-seq technology,
respectively. The proteomic profile obtained is highly dependent on the extraction
procedure used, with quickness, handling and robustness of protein extraction
methodologies being important criteria [425,435-437]. Before protein
concentration, we used SDS-PAGE to compare the lysis efficiency of sonication
and glass bead disruption of S. epidermidis biofilm cells (Figure 3.1).
Figure 3.1.: SDS-PAGE before protein concentration and respective optical density traces. 1 -
Protein profile obtained with FastPrep and SDS buffer extraction; 2 - Protein profile obtained with
FastPrep and CHAPS buffer extraction; 3 - Protein profile obtained with sonication and SDS buffer
extraction; 4 - Protein profile obtained with sonication and CHAPS buffer extraction. MW –
molecular weight (KDa).
Cellular lysis by the glass bead disruption method produced a higher protein yield
compared to the performed sonication cycle. Due to sample and protein
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properties, precipitation may be required as a treatment to reduce or eliminate
substances which could interfere with protein identification, as well as to
concentrate proteins [438]. However, it is known that protein precipitation leads to
specific changes in the protein composition of proteomic samples. These
modifications depend, mainly, on the specific structure of the protein rather than
the precipitating agent used [439]. Nevertheless, proteins recovered in each
extraction method were precipitated, solubilised and quantified, followed by SDS-
PAGE and LC-MS/MS analysis.
A total of 453 S. epidermidis proteins were identified, which corresponds to
17.96% of the predicted proteome (total of 2522 for S. epidermidis RP62A strain in
UniProtKB database, at 29.11.2013) with an increased confidence (FDR was
below 5.5% among replicates). Venn diagram [384] demonstrated that 158
proteins were common to all extraction conditions (Figure 3.2) .
Figure 3.2.: Overlap of proteins found in each tested condition determined using Venn diagram.
FastPrep – extraction with bead beating; SON – sonication.
A total of 361 proteins were identified in FastPrep lysates with SDS, 391 in
FastPrep with CHAPS, 359 in sonication lyses with SDS and 175 proteins after
sonication in the CHAPS extraction buffer. The FastPrep protocol seemed to be
the most efficient to lyse cells within S. epidermidis biofilms. Additionally, the
CHAPS extraction buffer resulted in the identification of a higher number of
proteins, compared to the SDS extraction buffer. Interestingly, this last finding,
diverges from the work described by Encheva el al. [440], where it was shown that
SDS gave a higher protein yield as compared to CHAPS, in an analysis of the
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Streptococcus pneumoniae proteome. SDS is an anionic detergent, used as a
surfactant in protein denaturation, breaking lipid-lipid interactions and lipid-protein
interactions rather than protein-protein interactions [441]. SDS is known to be very
effective at solubilising almost all proteins [442,443]. However, it denatures them,
causing loss of their native conformations and functions [444]. Alternatively,
zwitterionic detergents such as CHAPS minimize protein-protein interactions
[431,445]. Differences in extraction efficiency support the importance of extraction
buffer to optimize protein yield or to increase yields of groups of proteins.
Next, GO annotation, incorporating molecular function, biological processes and
cellular component of proteins recovered from each extraction condition was
analyzed. The main differences were observed in molecular function enriched
categories (Figure 3.3).
Figure 3.3.: GO classification. Molecular function specific terms with statistically significant
enrichment (p < 0.05, FDR-corrected).
The GO terms adenyl nucleotide binding (GO:0030554) and nucleic acid binding
(GO:0003676) were only found in protein extraction performed with FastPrep lysis.
Similarly, the GO terms for metal ion binding (GO:0046872), cation binding
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(GO:0043169) and ion binding (GO:0043167) were only found enriched in
extractions performed with SDS buffer. These findings may be explained by the
interaction established by SDS and cationic metal ions, due to the anionic head
group of SDS [446]. While some studies showed that mechanical disruption of
bacterial cells enhances the identification of cytoplasmic proteins [447,448], a
number of cell membrane, secreted and cell surface proteins were also identified
here. Membrane proteins are hydrophobic and they are present in low levels,
since they are unstable and often aggregate, causing problems in analyzing
membrane protein extractions [449]. However, within a heterogeneous protein
properties set, it is difficult to find the conditions which will solubilise all proteins,
including most membrane proteins, since not all are equally hydrophobic [450].
In an attempt to search for a methodological impact in the intrinsic properties of
identified proteins, GRAVY score (grand average of hydropathy), molecular weight
and isoelectric point (pI) were analyzed (Figure 3.4).
Figure 3.4.: Intrinsic properties of proteins. GRAVY (A), pI (B) and molecular weight (C) for each
condition.
Overall, pI, protein molecular weight and GRAVY score presented a similar
tendency, among the tested conditions, with a few exceptions. Most of the
identified proteins had a GRAVY score between -0.5 and -0.25 (Figure 3.4A).
CHAPS extraction buffer allowed separation of a higher number of hydrophilic
proteins (GRAVY score lower than -1.00) compared to SDS extraction buffer.
Although gel-based approaches, e.g. SDS-PAGE, may allow recovery of a
significantly higher number of hydrophobic proteins, these extraction methods
seemed to be less efficient at isolating hydrophobic proteins (positive GRAVY
score). However, a few cell membrane proteins were identified, despite having
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high hydrophobicity. Our approach allowed us to identify only 3.3% of hydrophobic
proteins. In proteins inferred from homology or with evidence at protein level (total
of 997 proteins in UniProtKB/Swiss-Prot at 29.11.2013), the number of
hydrophobic proteins corresponds to 13.04%. Concerning pI, most of the isolated
proteins showed a value between 4-6 or 9-10, similar to proteins inferred from
homology or with evidence at protein level. More than 60% of proteins had a pI
between 4 and 6 (Figure 3.4B). Gumber et al. [451] showed that non-ionic
detergents, such as Tween20 and Triton X-100 were more efficient at extracting
proteins with high pI. Conversely, CHAPS associated with urea was shown to
extract more proteins with low pI [451]. Regarding molecular weight, most of the
proteins presented a mass between 10 and 50 KDa (Figure 3.4C), which is also
the most common range among the proteins inferred from homology or with
evidence at the protein level. The FastPrep protocol allowed separation of higher
numbers of proteins with more than 90 KDa compared to sonication. Moreover,
the CHAPS extraction buffer combined with FastPrep seemed to be more efficient
than SDS in obtaining proteins of less than 10 KDa. Independent of the
methodological approach, a predominance of hydrophilic proteins, with 10-50 KDa
and a pI between 4 and 6 was observed. Overall, major differences were not
clearly found in molecular weight, GRAVY and pI, and only the GO analysis
showed evident differences between SDS and CHAPS detergent extraction
buffers.
3.3.2. Transcriptomic characterization
Whole transcriptomic profile of S. epidermidis biofilm cells was obtained by RNA-
seq. This methodology represents a valuable method to measure mRNA
expression levels, since RPKM normalization allows comparison of transcript
levels among and within samples [381]. A total of 2069 genes were found with a
RPKM value above 1.00, which corresponds to 77.72% of the S. epidermidis
genome (total of 2662 for RP62A strain in GenBank). More than 50% of transcripts
presented RPKM values up to 250. The most represented GO slim terms in each
RPKM group (RPKM < 150, 151 > RPKM < 250 and RPKM > 250) are
represented in Figure 3.5.
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Figure 3.5.: GO classification of RNA-seq data. Five most represented GO slim terms of biological
processes (A), molecular functions (B) and cellular components (C).
Additionally to common GO terms, RPKM values above 250 showed a
predominance of catabolic (GO:0009056) and carbohydrate metabolic processes
(GO:0005975) within the biological process GO category (Figure 3.5A). In
contrast, transcripts with RPKM lower than 250 were associated with transport
(GO:0006810) and cellular amino acid metabolic processes (GO:0006520), in
addition to common GO terms. Molecular functions related to RNA binding
(GO:0003723) and kinase activity (GO:0016301) were only found in transcripts
with RPKM higher than 250 (Figure 3.5B). Regarding cellular components (Figure
3.5C), protein complex category (GO:0043234) was amongst the most
represented transcripts with RPKM lower than 150. Amongst the 10 most
expressed transcripts are genes involved in response to stimulus, translation,
catabolic processes and non-coding RNAs (Table 3.1).
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Table 3.1.: List of the 10 genes with higher RPKM values found in transcriptomic analysis and
respective function.
Gene RPKM Gene function
SERP_SeSRP1 299510.4 Non-coding RNA involved in protein export
SERP_SetmRNA1 372738.7 Transfer-messenger RNA
SERP1273 28468.9 Universal stress protein
SERP2379 27311.7
Diacetyl reductase [(S)-acetoin forming] which
catalyzes the irreversible reduction of 2,3-butanediol
to (S)-acetoin in the presence of NADH
asp23 24019.2 Alkaline shock protein 23 which may play a key rolein alkaline pH tolerance
arcC 11927.2 Carbamate kinase
SERP2220 13204.3 Universal stress protein
SERP_SernpB1 15829.8 Non-coding RNA
spoVG 13016.0 Septation protein
SERP2343 11865.1 Uncharacterized protein
These were expected results since during growth, bacteria need to obtain energy.
Moreover, increased expression of certain classes of genes may be related to an
adaptive response [110,452-455]. It is well known that glucose has a key role in
biofilm physiology since is generally used to promote biofilm growth in vitro
[96,380]. However, high concentrations of glucose affect biofilm gene expression
[380].
3.3.3. Comparative proteomic and transcriptomic analysis
In order to compare proteomic and transcriptomic profiles, mass spectrometry and
RNA-seq data were compared. Large scale proteomic experiments have been
conducted using emPAI to determine, in a single LC-MS/MS experiment, the
relative quantitation of proteins based on protein coverage by the peptide matches
in a database search result [456-458]. Since the emPAI value has a linear
correlation with protein concentration, it allows a more accurate estimation of
protein abundance, as compared to simple peptide or spectral count [458,459]. In
order to obtain an estimation of protein abundance, two independent experiments
were performed. The emPAI values presented the same tendency among proteins
found in each replicate, as indicated by Pearson correlation (Pearson’s r
correlation), which varied between 0.81 and 0.99. Based on these results, we
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chose to calculate the emPAI average for further analysis. Extremely abundant
proteins may affect the efficiency of protein identification because of ionization
suppression and detector saturation as well as the limited loading capacity of LC
columns [458]. We observed that bead beating lysis led to a lower percentage of
identified proteins with low emPAI (0-0.20) compared to those identified following
sonication (Figure 3.6).
Figure 3.6.: emPAI distribution among the distinct conditions.
Moreover, a combination of bead beating and CHAPS extraction buffer showed
more proteins with higher emPAI values (> 5.00). Protein separation by SDS-
PAGE and in-gel digestion decreased sample complexity and, consequently,
contributed to avoiding suppression by extremely abundant proteins. Since
proteins with similar abundances may functionally be correlated, proteins common
to all conditions were further analyzed using CLUSTER 3.0 [460] (Figure 3.7). We
found four main clusters which resulted from the hierarchical clustering (two main
biological processes are represented in Figure 3.7.). Proteins with lower emPAI
tended to be involved in biosynthetic and cellular nitrogen compound metabolic
processes (cluster A and D). Clusters B and C include mainly proteins with higher
emPAI values. Protein cluster B is mainly related to biosynthetic processes and
translation. Protein cluster C is related to biosynthetic and catabolic processes.
Catabolic process was also found as one of the most prevalent GO term in
transcripts with higher RPKM (Figure 3.5A).
CHAPTER 3.
Biomedical Sciences PhD 61
Interestingly, proteins with the highest emPAI values
presented translation among the main biological
processes. In accordance, molecular functions, such as
structural constituent of ribosome and RNA binding,
were found among these proteins. However, these
biological functions were not evidenced in transcripts
with the highest RPKM. More precisely, instead of
translation, response to stress was a biological process
found significant in these transcripts, among others. In
relation to molecular functions, only oxidoreductase
activity was a significant class. Despite a biological
condition is not characterized by the most expressed
transcripts or proteins, it is of utmost importance to
undertake a whole bacteriome analysis using multi-
approaches. RPKM obtained by RNA-seq was next
compared to emPAI values obtained from protein
extraction experiments performed with FastPrep and
sonication (Figure 3.8).
Correlations between mRNA transcripts and protein
abundance obtained with FastPrep lyses were 0.37 and
0.36 (Pearson coefficient) in SDS and CHAPS extraction
buffer, respectively. A somewhat smaller correlation
coefficient was observed in sonication lyses with SDS (r
= 0.30) and CHAPS extraction buffer (r = 0.22). Although
this is not a strong correlation, our results are in
agreement with correlation data previously described in
bacteria [433]. When we zoomed Figure 3.8A and Figure
3.8B, we found that several proteins did not correlate
with mRNA expression level. The main biological
processes of these proteins are translation (when emPAI
is higher than RPKM) and response to stress (when
Figure 3.7.: emPAI hierarchical clustering. Clusters and two
most represented biological function of the common proteins in
each of the tested conditions generated in CLUSTER 3.0 and
based on emPAI average from replicates (Slim terms).
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emPAI is lower than RPKM). Interestingly, dormancy is associated with low
metabolic activity, leading to a decrease expression of transcripts involved in
translation [214]. This suggests that these biological processes, in particular, may
contribute to a lower correlation between transcriptomic and proteomic data. In
almost every organism, transcript abundances only partially predict protein
abundances, which suggests that other modes of regulation must be involved to
explain how the levels of proteins are set within cells [432]. Also, the localization of
proteins may display different correlations when compared to global correlation
[461].
Figure 3.8: Protein and transcript correlation in S. epidermidis biofilms grown in glucose enriched
medium. FastPrep SDS (A), FastPrep CHAPS (B), SON SDS (C), SON CHAPS (D). Linear
regression (R2), Pearson correlation (Pearson’s r) and number of proteins (n) are shown. The 95%
confidence interval is shown is each condition, represented in grey dashed line. All correlations
were significant (p < 0.01). SON - sonication
Despite direct correlation between proteins and mRNA is lower than 0.50, besides
noise and experimental errors [462], several levels of regulation of transcripts and
proteins may cause variability, such as transcription, post-transcription and post-
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translation regulation. Protein folding and post-translational modifications as
phosphorylation, glycosylation, acetylation, proteolysis, methylation, lipidation,
among others, are the most significant modifications [463-466]. Phosphorylation,
such as found in LRTQKIVFS(Phospho)IGLCYSILMALSR peptide (Q5HLC3),
corroborate that protein modifications increase phenotypic variability. These
regulation mechanisms may explain why transcripts and proteins levels have a low
correlation, among bacteria. Previously, it was shown that, in S. aureus, serine
and threonine phosphorylations was associated with metabolic activity, virulence
and translation [467]. This addresses the biological importance of regulation
processes and modifications over proteins.
3.4.Conclusion
Similar to other studies, we demonstrated that protein extraction methods affect
the proteome characterization of S. epidermidis biofilms. It is assumed that an
efficient protein extraction method is crucial to ensure successful proteome
analysis. A combination of mechanical and chemical lyses or enzymatic lysis
provides a better methodology to extract proteins from S. epidermidis biofilms. The
ideal choice of a detergent is still empirical, although, optimization of sample
preparation is fundamental to correctly analyze the cell proteome. Our data
suggest that a higher number of total proteins from S. epidermidis biofilm can be
extracted and recovered by a combination of glass beads mechanical lysis with
CHAPS extraction buffer. However, only mildly hydrophobic proteins can be
solubilised with SDS or CHAPS. Also, the use of SDS extraction buffer led to an
enhancement of metal ion binding proteins. A few lyse buffers have been used to
enhance protein extraction, but one buffer is not sufficient for all purposes. This
study emphasizes the need for a detailed study over extraction buffers that should
be used for each experiment in order to identify the most efficient extraction
methodology.
More important, we provide evidences that transcriptomic and proteomic data
present a similar correlation to other bacteria, despite the detergent extraction
buffer used. Interestingly, proteins involved in translation or response to stress
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appear to be those which less correlate with the correspondent transcript. Several
“omics” may provide useful information instead of individual transcriptome or
proteome analysis, since it gives an integrative view of a specific physiological
state.
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PROTEOMIC PROFILE OF DORMANCY WITHIN S. EPIDERMIDIS
BIOFILMS USING ITRAQ AND LABEL-FREE STRATEGIES
Summary
Here, we provide a detailed characterization of the quantitative proteomic profile of
S. epidermidis biofilms with induced and prevented dormancy. A total of 427 and
409 proteins were identified by label-free and label-based quantitative
methodologies, respectively. From these, 29 proteins were found to be
differentially expressed between S. epidermidis biofilms with prevented and
induced dormancy. Proteins overexpressed in S. epidermidis with prevented
dormancy were associated with ribosome synthesis pathway, which reflects the
metabolic state of dormant bacteria. In the opposite, underexpressed proteins
were related to catalytic activity and ion binding, with involvement in purine,
arginine and proline metabolism. Additionally, GTPase activity seems to be
enhanced in S. epidermidis biofilm with induced dormancy. The role of magnesium
in dormancy modulation was further investigated with bioinformatics tool based in
predicted interactions. The main molecular function, of proteins which strongly
interact with magnesium, was nucleic acid binding. Different proteomic strategies
allowed to obtain similar results and evidenced that prevented dormancy led to an
expression of a markedly different repertoire of proteins in comparison to the one
of dormant biofilms.
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4.1. Introduction
The transcriptomic profile of S. epidermidis biofilms with different proportions of
dormant bacteria confirmed that the translation process was related to the
proportion of dormant bacteria (Chapter 2). Transcriptomic data analysis also
suggested that oxidation-reduction processes were associated with dormancy.
However, the expression level of a gene does not necessarily indicate the amount
of protein produced, nor its biological activity [468]. Similar to other bacteria [433],
S. epidermidis transcripts and proteins showed a modest correlation (Chapter 3),
which suggests that transcript regulation and protein modifications may determine
the biological importance of a gene [463,464,466].
Currently, proteomic tools allow simultaneously the identification and comparison
of protein expression in different pathophysiological conditions. Quantitative
proteomic analysis based on mass spectrometry may be achieved, among others,
by stable isotope labeling, such as iTRAQ (isobaric tags for relative and absolute
quantitation) or by label-free spectral counting, such as emPAI [469]. In one
experimental setup, iTRAQ has the capability of multiplexing up to eight samples
[470] where proteolytic peptides are chemically labeled with amine-speciﬁc
isobaric tags. Then, upon induced fragmentation in the mass spectrometer,
peptides yield different reporter ions in 113–121 m/z range (in the case of a 8-plex
experiment) [470]. Alternatively, the relative protein abundance, emPAI, offers
label-free relative quantitation of a protein in a complex sample, based on protein
coverage by the peptide matches which is proportional to the protein abundance in
a cell [458]. The ability to accurately quantify proteins by label-free spectral
counting depends on the number of spectra obtained and the sample coverage
[469]. Thus, apart from relative quantitation, label-free also allows a qualitative
analysis based on the number of identified proteins. Conversely, iTRAQ
methodology do not allow to identify unique proteins, since the protein ratio is only
calculated when the protein is present in both tested conditions.
The purpose of our study was to describe quantitative profile of S. epidermidis
biofilms with induced and prevented dormancy, using label-free and label-based
proteomic approaches. To achieve this, total proteins from S. epidermidis biofilms
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with different proportion of dormant cells were quantified by iTRAQ coupled with 2-
dimensional LC-MS/MS and by SDS-PAGE-LC-MS/MS (GeLC-MS/MS).
4.2. Materials and Methods
4.2.1. Biofilm growth conditions
One colony of S. epidermidis 9142 (isolated from blood culture [380]) was
inoculated in TSB (LiofilChem) and incubated at 37 ºC in an orbital shaker at
120rpm for 18 h. The overnight culture was adjusted to an optical density at 640
nm of 0.250 (±0.05) with TSB and 10 µL of the suspension was transferred into a
24-well plate (Orange Scientific) containing 1 mL of TSB supplemented with 0.4%
glucose (v/v) (Fisher Scientific) or TSB 0.4%G enriched with 20 mM magnesium
chloride (MgCl2) (Merck), to form biofilms. The culture plates were then incubated
at 37 ºC in an orbital shaker at 120 rpm for 24 h. After this period, the culture
medium was removed and replaced by fresh TSB supplemented with 1% glucose
(v/v) or TSB 1%G containing 20 mM MgCl2. Biofilms were then allowed to grow in
these same conditions for an additional 24 h. Next, biofilm culture medium was
removed and biofilms were washed twice with PBS. Then, bacteria within the
biofilms were resuspended in 1 mL of PBS. Biofilm dormancy was assessed as
previously described [138]. Briefly, the number of CFU/mL in each biofilm growth
condition was determined using the spread plate method in TSA (LiofilChem). A
reduction of about one log difference is typically expected in similarly grown
biofilms without addition of Mg2+.
4.2.2. Preparation of protein extracts
For total protein extraction, biofilms were directly scrapped and resuspended with
detergent extraction buffer, 25 mM Tris-HCl (pH = 7.2) (Pharmacia Biotech), 10
mM CHAPS (Sigma-Aldrich), 0.5 M NaCl (VWR), 5% glycerol (Sigma-Aldrich) and
1 mM PMSF (Sigma-Aldrich). Then, mechanical lysis was performed in a bead
beating using glass beads of 0.1 mm (Sigma-Aldrich) in a FastPrep® cell disruptor
(BIO 101, ThermoElectron Corporation) (3 cycles of 30 s and 6.5 m/s). After lysis,
cell debris were removed by centrifugation (15,000g for 15 min at 4 ºC). Then,
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proteins were precipitated with 20% of TCA-cold acetone and quantified using the
RC-DC assay (Bio-Rad), following the manufacturer’s instructions.
4.2.3. Gel electrophoresis (SDS-PAGE), in-gel protein digestion and protein
identification
40 µg of protein were incubated with SDS 10% (w/v) (USB Corporation), 0.5 M
Tris-HCl (pH 6.8), glycerol, mercaptoethanol (Sigma-Aldrich) and bromophenol
blue (w/v) for 5 min at 100 ºC. Then, samples were loaded on a SDS-PAGE and
proteins were separated at a constant voltage (150 V) for 50 min. The gel was
stained with colloidal Coomassie G-250 and entire gel lanes were manually
excised into 16 gel slices for in-gel digestion with trypsin TPCK treated (ABSciex).
Peptides extraction was made with 10% formic acid/ACN. Peptides were dried in a
SpeedVac (Thermo Savant, Thermo Scientific) and were dissolved in 5% ACN
(MS grade, VWR), 0.1% formic acid (Fluka Analytical, Sigma-Aldrich) and 0.1%
TFA (Sigma-Aldrich). Separation of tryptic peptides by nano-HPLC was performed
on the module separation Ultimate 3000 (Dionex, Thermo Fisher Scientific) using
a capillary column (Pepmap100 C18; 3 μm particle size, 0.75 μm internal
diameter, 15 cm in length). A gradient of solvent A, (water/ACN/TFA (98:2:0.05,
v/v/v)) to solvent B (water/ACN/TFA (10:90:0.045, v/v/v)) was used. The
separation of 2 μg/μL sample was performed using a linear gradient (5-50% B for
30 minutes, 50-70% B for 10 min and 70-5% A for 5 min) with a flow rate of 0.3
µL/min. The eluted peptides were mixed with a continuous flow of α-CHCA matrix
solution (270 nL/min, 2 mg/mL in 70% ACN/0.1% TFA and internal standard Glu-
Fib at 15 ftmol) and were applied directly on a MALDI plate in 20 s fractions using
an automatic fraction collector Probot (Dionex). Mass spectra were obtained on a
matrix assisted laser desorption/ionization–time of flight MALDI TOF/TOF mass
spectrometer (4800 Proteomics Analyzer, Applied Biosystems) in the positive ion
reflector mode and obtained in the mass range from 700-4500 Da with 900 laser
shots. A fragmentation voltage of 2 kV was used throughout the automated runs.
The spectra were processed and analyzed by the T2S (v1.0, Matrix Science Ltd.)
and submitted in Mascot software (v.2.1.0.4, Matrix Science Ltd.) for
protein/peptide identification based on MS/MS data using the following criteria:
trypsin as enzyme; a maximum of two missed cleavages; mass tolerances of 40
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ppm for peptide precursors, mass tolerance of 0.6 Da was set for fragment ions.
The local FDR was calculated by searching the spectra against SwissProt
(Firmicutes, release date 06.02.2013) decoy database (false positive
peptides/(false positive peptides + total peptides))*100). Protein identification
based on a single peptide hit had a minimum individual score of 29 (95%) and a
minimum sequence tag of four amino acids (five consecutive peaks in the MS/MS
spectrum). Quantification was performed using emPAI. GO terms [385] and KEGG
pathways [386] in each condition were determined using STRING database
(version 9.1) (accessed at 10.12.2014) [387]. Independent replicates were
performed with 22 pools of S. epidermidis biofilms, for each condition.
4.2.4. iTRAQ labeling
An in-solution digestion was performed for iTRAQ labeling, as previously
described [471]. Brieﬂy, 100 µg of protein was precipitated with 6 volumes of cold
acetone at -20 ºC for 3 h. After samples centrifugation and acetone decantation,
pellets were resuspended with triethylammonium bicarbonate buffer (TEAB) (0.1
M, pH 8.5) (Sigma-Aldrich) and 2% SDS to achieve a final concentration of 0.05%.
Samples were then reduced with 50 mM tris(2-carboxyethyl)phosphine (TCEP)
(Sigma-Aldrich) for 1 h at 37ºC with agitation. Then, samples were alkylated with
10 mM S-methyl methanethiosulfonate (MMTS) (Sigma-Aldrich) for 10 min at room
temperature with agitation. Trypsin was added to each sample and the digestion
was performed for 18 h at 37 ºC. Digested sample peptides were subsequently
labeled with the iTRAQ® reagent - 8plex (ABSciex) following the protocol provided
by the manufacturer. Briefly, labels were reconstituted in 60% isopropanol, added
to each sample peptides and incubated for 2 h at room temperature with agitation.
Peptides from S. epidermidis biofilms with induced dormancy (1%G) were labeled
with 119 isobaric reagent and peptides from biofilms with prevented dormancy
(1%G + Mg2+) were labeled with 121 isobaric reagent. The reaction was stopped
by adding water and acidification with formic acid. Labeled samples were then
combined and dried in SpeedVac.
Then, labelled peptides were separated from an adapted multidimensional LC
approach, as described by Vitorino et al., based on high pH for first dimension
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peptide chromatography with a C18 reverse phase HPLC column and acidic pH
for second one [472]. Thus, sample loading was performed at 200 µL/min with
buffers (A) 2% ammonium hydroxide and 0.014% formic acid in water, pH 10 and
(B) 2% ammonium hydroxide and 90% ACN in water, pH 10. After 5 min of sample
loading and washing, peptide fractionation was performed with linear gradient to
70% B over 85 min. Sixty fractions were collected, dried in a SpeedVac and
resuspended in 5% ACN and 0.1% TFA. Collected fractions were then separated
by LC. Brieﬂy, peptides loaded onto a C18 pre-column (5 mm particle size, 5 mm;
Dionex) connected to a reverse phase column PepMap100 C18 (150 mm_75 mm
i.d., 3 mm particle size). The ﬂow rate was set at 300 nl/min. The mobile phases A
and B were 2% ACN and 0.05% TFA in water, and 90% ACN with 0.045% TFA in
water, respectively. The gradient started at 10 min and ramped to 60% B till 50
min and 100% B at 55 min and retained at 100% B till 65 min. The separation was
monitored at 214 nm using a UV detector (Dionex/LC Packings). Using the micro-
collector Probot (Dionex/LC Packings) and, after a lag time of 5 min, peptides
eluting from the capillary column were mixed with a continuous ﬂow of α-CHCA
matrix solution (in internal standard Glu-Fib) and were directly deposited onto the
LC-MALDI plates. The spectra were generated and processed with 4800 MALDI-
TOF/TOF. Protein identification based on MS/MS data were performed with
ProteinPilotTM software (v.4.04, AB Sciex) using Paragon search method.
SwissProt from S.epidermidis strain RP62A (Firmicutes, release date 06.02.2013)
was used as protein database. Default search parameters used were: trypsin as
the digestion enzyme with 2 missed cleavages, 40 ppm tolerance,
carbamidomethyl modification on cysteine residue, iTRAQ 8-plex modification of
N-terminal and lysine peptide residues as fixed modification. Additionally,
biological modiﬁcations with emphasis on methionine oxidation, deamidation and
iTRAQ 8-plex modification of tyrosine residue and deamidation, were considered
variable modiﬁcations. Bias correction was applied and proteins were identified
with a confidence level of 95%. Proteins were found to be differentially expressed
when p < 0.05 (FDR-corrected). Proteins were considered overexpressed in
prevented dormancy when the iTRAQ ratio was above 1, and underexpressed
when iTRAQ ratio was lower than 1. GO and KEGG were determined using
STRING as described in 4.2.3. section.
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4.2.5. Immunodetection and identification of oxidized proteins
Carbonylated proteins were assayed as previously described [473,474]. Briefly,
whole cell proteins from both conditions were separated by isoelectric focusing
with immobilized pH gradient (IPG) strips non-linear pH 3–10 gradient (GE
Healthcare). Then, each strip was incubated with 12% SDS for 30 min at room
temperature and derivatized with 20 mM DNPH (2,4-dinitrophenylhydrazine)
(Acros Organics) in 10% TFA for 30 min at room temperature, in the dark. The
reaction was stopped with equilibration buffer (2% (w/v) SDS, 6 M urea, 30%
glycerol, 0.05 M Tris–HCl (pH 8.8) and 20 mg/ml DTT for 30 min at room
temperature. The second dimension was obtained by SDS-PAGE. Then, gels
were stained with colloidal Coomassie G-250 or gels were transferred onto a
nitrocellulose membrane. Immunodetection was performed using anti-2,4-
dinitrophenol (DNP) antibody (Merck) and detected by enhanced
chemiluminescence ECL (Amersham Pharmacia Biotech) according to the
manufacturer's procedure. Images were recorded using X-ray ﬁlms (GE
Healthcare) and the ﬁlms and the gels were scanned in Molecular Imager Gel Doc
XR+ system (Bio-Rad) and analyzed with QuantityOne software (v. 4.6.9, Bio-Rad).
Protein spots reactive to anti-DNP antibody were manually excised and an in-gel
digestion was performed as described in 4.2.3. section. Peptides were
resuspended and directly deposited onto 384-well MALDI plates (Applied
Biosystems) with α-CHCA matrix solution. α-CHCA matrix solution was prepared
by diluting 2.5 mg/mL of α-CHCA in ACN 70%/ TFA 0.3%. Experiments were
carried in duplicate. Peptide mass spectra were obtained as referred in 4.2.3.
section. Mass spectra were processed and analyzed by the Global Protein Server
(GPS) Workstation (Applied Biosystems). Searches were performed against the
SwissProt protein database for Firmicutes (release date 06.02.2013). The
database search parameters were: mass tolerance of 40 ppm for precursor ions
and 0.4 Da for fragment ions; trypsin digestion with two missed cleavages. Protein
identity was accepted at the 95% confidence level.
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4.3. Results
4.3.1. Label-free data analysis
The work reported here represents a multi-approach to determine the protein
changes in dormancy within S. epidermidis biofilms, using a previously described
model based in Mg2+ [138].
After GeLC-MS/MS separation and identification of proteins from induced (1%G)
and prevented (1%G + Mg2+) dormancy in S. epidermidis biofilms, label-free
qualitative and relative quantitation analysis were performed from two independent
replicates. For qualitative analyses, Venn diagram was generated with identified
proteins in each condition, using Venny tool from BioinfoGP [384] (Figure 4.1).
Figure 4.1.: Venn diagram summarizing the overlap between proteins identified by label-free
methodology in S. epidermidis biofilms with prevented (1%G + Mg2+) or induced (1%G) dormancy.
A total of 378 and 387 proteins (FDR < 5%) were identified in induced and
prevented dormancy, respectively. Statistically significant GO terms (including
biological processes and metabolic functions) for proteins found in each condition
are detailed in Figure 4.2.
Despite no major differences were found, cell wall organization or biogenesis
(GO:0071554) was a biological process only found statistically significant in S.
epidermidis biofilms with induced dormancy (including the MurC, Ddl, MurG, LtaS,
Atl, DltC, MurA1, FemB, FemA, DltA, MurB, FemX and GlmU proteins). GTPase
activity (GO:0003924) was a molecular function only found statistically significant
in S. epidermidis biofilms with induced dormancy. Examples of such proteins
included SERP0696, InfB, PrfC, Obg, MnmE, UreG, Era, LepA, FtsZ, FusA and
EF-Tu. Among them, only seven proteins were common to the proteome of S.
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epidermidis biofilm with prevented dormancy. Interestingly, these proteins are
involved in the nucleotide metabolic process and present ion binding activity.
Figure 4.2.: Significant biological processes and molecular functions terms in S. epidermidis
biofilms proteome with prevented (1%G + Mg2+) and induced (1%G) dormancy (p < 0.05, FDR-
corrected). Data obtained by label-free methodology. Classes with a p-value ≤ 0.05 were
considered statistically significant.
Furthermore, cofactor metabolic process (GO:0051186) was a biological process
only significant in prevented dormancy. Additionally, hydrolase activity, acting on
carbon-nitrogen bonds (GO:0016810) and lyase activity (GO:0016829) were
molecular function categories only found significant in prevented dormancy.
Among all the proteins identified in both conditions, only 40 proteins were
exclusively assigned to dormancy in S. epidermidis biofilms (Figure 4.1).
Conversely, only 49 proteins were exclusively assigned to S. epidermidis biofilms
with prevented dormancy (Figure 4.1). Thus, Figure 4.3 shows the three most
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represented biological processes and molecular functions in unique proteins found
in each condition.
Figure 4.3.: The three most prevalent biological processes and molecular functions terms in
proteins only found in S. epidermidis biofilms in prevented (1%G + Mg2+) or induced (1%G)
dormancy. Data obtained by label-free methodology.
Main differences were found in molecular function annotations. Herein, GTPase
activity (GO:0003924), structural constituent of ribosome (GO:0003735) and
structural molecule activity (GO:0005198) were categories predominant in induced
dormancy. Conversely, DNA binding (GO:0003677) (including AddA, Rex, GreA,
LexA, GrlA, PhoP and PcrA proteins) and ATPase activity (GO:0016887)
(including AddA, TagH, GrlA, Rho, PcrA and MetN1 proteins) were predominant in
S. epidermidis biofilm with prevented dormancy.
In order to analyze relative quantitation of label-free data, emPAI was compared
amongst biological replicates. The reproducibility of data collected from the two
biological replicates showed a Pearson’s correlation indicating good reliability of
emPAI data, with a correlation higher than 0.810 in both conditions. Thus, we used
emPAI average for further analysis.
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4.3.2. Label-based data analyses
iTRAQ provide the possibility to quantitatively examine a large number of proteins
for differential expression [470,475]. First, samples were labeled, pooled,
fractionated by HPLC and then, separated by liquid chromatography and analyzed
by tandem mass spectrometry (MS/MS). Using this approach, a total of 409
proteins were identified. Among them, 408 proteins had a calculated ratio value.
Herein, a total of 29 proteins were differentially expressed, wherein 16 proteins
were overexpressed and 13 proteins were underexpressed in S. epidermidis
biofilms with prevented dormancy (Table 4.1). The two most represented biological
processes, molecular functions and KEGG pathways in differently expressed
proteins were detailed in Figure 4.4.
Figure 4.4.: The two most prevalent biological processes, molecular functions and KEGG
pathways in statistically significant overexpressed and underexpressed proteins from S.
epidermidis biofilms with prevented dormancy. Data obtained by label-based methodology.
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Table 4.1.: Significantly expressed proteins in iTRAQ.
Protein Accessionnumber Protein function
Peptides
(95%)
Ratio
(Mg2+/1%G)
ArgF Q5HKJ4 Ornithine carbamoyltransferase 20 0.4848
SERP1299 Q5HNH0 UPF0478 protein SERP1299 6 0.5015
SERP1140 Q5HNX4 UPF0365 protein SERP1140 10 0.5811
BetA Q5HL11 Choline dehydrogenase 7 0.6084
ArcA Q5HKU2 Arginine deiminase 11 0.6399
GuaA Q5HRX1 GMP synthase [glutamine-hydrolyzing] 5 0.696
Atl Q5HQB9 Bifunctional autolysin 12 0.7037
RplT Q5HNM5 50S ribosomal protein L20 7 0.711
GlnA Q5HPN2 Glutamine synthetase 8 0.7219
RpoC Q5HRK9 DNA-directed RNA polymerasesubunit beta 22 0.7579
EF-Tu Q5HRK4 Elongation factor Tu 21 0.7643
SERP2115 Q5HL72 Pyruvate oxidase 2 0.7771
RpoB Q5HRL0 DNA-directed RNA polymerasesubunit beta 18 0.7773
SERP1777 Q5HM52 Iron compound ABC transporter,iron compound-binding protein 4 1.3045
GpmI Q5HQV1
2,3-bisphosphoglycerate-
independent phosphoglycerate
mutase
20 1.4027
Pgk Q5HQV3 Phosphoglycerate kinase 17 1.4537
RpmI Q5HNM4 50S ribosomal protein L35 4 1.4606
RplX Q5HM10 50S ribosomal protein L24 3 1.4924
Efp Q5HP20 Elongation factor P 4 1.5269
GroS Q5HMZ0 10 kDa chaperonin 7 1.5296
GlmU Q5HRQ6 Bifunctional protein GlmU 1 1.596
RplL Q5HRL2 50S ribosomal protein L7/L12 7 1.6098
PdhC Q5HQ74
Dihydrolipoyllysine-residue
acetyltransferase component of
pyruvate dehydrogenase complex
13 1.7096
RpsR Q5HRZ3 30S ribosomal protein S18 4 1.8413
SERP1917 Q5HLR6 Oxidoreductase, short chaindehydrogenase/reductase family 5 1.9109
RplY Q5HRQ4 50S ribosomal protein L25 2 2.0165
RpmB Q5HPW7 50S ribosomal protein L28 8 2.0485
EbpS Q5HP65 Probable elastin-binding proteinEbpS 3 2.3042
SERP0665 Q5HQ90 Uncharacterized protein 1 3.0005
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Additionally to ion binding, GO terms related to catalytic activity, such as hydrolase
(GO:0016810) (Atl and ArcA proteins), ligase (GO:0016874) (GlnA and GuaA
proteins) and nucleotidyltransferase (GO:0016779) (RpoC and RpoB proteins)
activity were associated with induced dormancy, since these GO terms were
underexpressed. Purine (ser00230), arginine and proline (ser00330) metabolism
were the most prevalent pathways in underexpressed proteins in biofilms with
prevented dormancy. Conversely, molecular functions, such as structural
constituent of ribosome (GO:0003735), structural molecule activity (GO:0005198)
(including RpmI, RplL, RpmB, RplX, RplY and RpsR proteins) and RNA binding
(GO:0003723) were associated with proteins more expressed in S. epidermidis
biofilm with prevented dormancy. Moreover, ribosome synthesis pathway
(ser03010, including RpmI, RplL, RpmB, RplX, RplY and RpsR proteins) was the
most prevalent KEGG pathway in overexpressed proteins, which shows an
involvement in translation process.
To elucidate the behavior of proteins which may be considered as Staphylococci
virulence factors [1,64], we analyzed label-based data and list here their iTRAQ
ratio: LipA (ratio = 1.13), ClpP (ratio = 0.96), ClpC (ratio = 0.96), ClpB (ratio =
0.93), PSMβ1 (ratio = 0.52), SitC (ratio = 0.80), AtlE (ratio = 0.70, p < 0.05), TagD
(ratio = 0.50), DltC (ratio = 0.45) and EbpS (ratio = 2.3, p < 0.05). However, only
AtlE (an autolysin, also involved in the attachment of S. epidermidis to abiotic
surfaces [79]) and EbpS (primary attachment [476]) had significant differences
between induced and prevented dormancy. Although, these proteins did not
present the same expression tendency. Interestingly, PSMβ1 (a non-cytolytic
modulin involved in in vitro detachment [89]) had a ratio of 0.52 but without
statistical significance. Although differences were not statistically significant in the
majority of proteins, virulence proteins seemed to be more expressed in biofilms
with induced dormancy.
Search Tool for Interactions of Chemicals (STITCH v.4) allows the creation of a
protein-chemical interaction network based on experimental data, databases, text
mining and predicted interactions [477]. Since the growth model previously
described includes addition of Mg2+ to obtain S. epidermidis biofilms with
prevented dormancy [138], STITCH resource was used to predict interactions of
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magnesium with unique proteins in prevented dormancy (identified by label-free)
and overexpressed proteins (identified by label-based methodology) (accessed at
10.12.2014). Additionally, we applied the Markov Cluster Algorithm (MCL) to
identify which proteins generate a cluster with magnesium (Figure 4.5). Five of
these proteins present nucleic acid binding function and three of them are
localized in cytoplasmic membrane.
Figure 4.5.: Cluster of magnesium-protein interactions generated and predicted by STITCH (v.4).
PhoP - alkaline phosphatase synthesis transcriptional regulatory protein PhoP; Efp - elongation
factor P; PcrA - ATP-dependent DNA helicase PcrA; MoaB - molybdenum cofactor biosynthesis
protein B; GroS - 10 kDa chaperonin; GrlA - DNA topoisomerase 4 subunit A; Rex - redox-sensing
transcriptional repressor Rex; SERP0996 - probable CtpA-like serine protease; SERP0611 - serine
protease HtrA-like;
4.3.3. Protein susceptibility to carbonylation
Oxidative modification of proteins can assume many forms such as
nitrotyrosination, carbonylation, methionine, sulfhydryl oxidation, etc. [478]. From
those, protein carbonyl content is widely used as a marker for oxidative stress,
since is considered to be a major form of protein oxidation [479]. Previously, we
compared the transcriptome of S. epidermidis biofilms with prevented and induced
dormancy, which suggested that oxidation-reduction molecular function was
increased in S. epidermidis biofilms with induced dormancy (Chapter 2). Following
this, we evaluated protein oxidation in S. epidermidis biofilms with prevented and
induced dormancy, namely protein carbonylation. A comparison of the 2-DE
immunoblots reveals a different carbonylated pattern between prevented and
induced dormancy (Figure 4.6).
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Figure 4.6.: Carbonylated proteins in induced (a) and prevented (b) biofilm dormancy. 1- TpiA
(triosephosphate isomerase); 2- EF-Tu (elongation factor Tu); 3- DnaK (chaperone protein DnaK);
4- GpmI (2,3-bisphosphoglycerate-independent phosphoglycerate mutase); 5- Fda (fructose-
bisphosphate aldolase class 1); 6- AhpF (alkyl hydroperoxide reductase subunit F); 7- GroEL (60
kDa chaperonin); 8- Pgk (phosphoglycerate kinase); 9- PfkA (ATP-dependent 6-
phosphofructokinase) 10- FusA (elongation factor G); 11- RpsA (30S ribosomal protein S1); 12-
GuaB (inosine-5'-monophosphate dehydrogenase).
Protein oxidation assessed by protein carbonyl content was mainly localized in the
region around pI of 5, with a molecular weight varying from 27 to 77 KDa. From
the most susceptible proteins to oxidation identified in both conditions showed that
TpiA and PfkA proteins seems to be associated to biofilm dormancy, whereas
RpsA and Pgk were more reactive to DNP in S. epidermidis biofilms with
prevented dormancy. A few more proteins presented the same oxidation
susceptibility among the two tested conditions.
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4.4. Discussion
Adaptation to local environment conditions contribute to physiological
heterogeneity of bacteria within biofilms [215]. A subpopulation of dormant
bacteria may be formed due to such unfavorable environment [215]. With a
purpose of characterize dormancy within biofilms, a global scale analysis of
transcriptome and proteome may be achieved with integration of high-throughput
techniques and quantitative proteomics. Recently, we assessed transcriptome
profile of S. epidermidis with prevented and induced dormancy. However, similarly
to other bacteria studies [433], comparison among S. epidermidis proteins and
transcripts showed a modest correlation (Chapter 3). Currently, quantitative
proteomics is still the bottleneck of comparative approaches, since the numbers of
identified proteins are most of the times behind the expected numbers [480].
Herein, two different proteomic approaches were used to quantify proteins of S.
epidermidis biofilms, since iTRAQ methodology do not allow to identify unique
protein in each condition, and it is used to validate protein expression data.
Based on label-free method, GO annotation strongly suggests the involvement of
GTPase activity and ion binding functions in dormancy within S. epidermidis
biofilms (Figure 4.2), since Mg2+ was used to avoid dormancy entry [138].
Furthermore, proteins only found in dormant condition had a high prevalence of
GTPase activity (Figure 4.3), which is in accordance with hydrolase activity of
underexpressed proteins, found in label-based approach. GTPase enzymes are
responsible for GTP hydrolysis and may be involved in several biological
functions, from cell cycle regulation, tRNA modification, energy metabolism,
stringent response and stress response, among others [481]. Furthermore, in a
nutrient limitation environment, GTP is converted by RelA (GTP
pyrophosphokinase) to (p)ppGpp [481,482]. RelA is a ribosome-associated
(p)ppGpp synthetase and a hydrolase, which is activated in response to amino-
acid starvation [483,484]. Interestingly, RelA was among the uniquely expressed
proteins in S. epidermidis biofilms with induced dormancy was RelA protein. Since
in deeper biofilm layers bacteria have limited access to nutrients, this may
increase their levels of (p)ppGpp [318], leading to higher expression of RelA
protein. In the opposite, prevented dormancy condition presented enhancement of
DNA binding and ATPase activity molecular functions, which is related to the
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higher number of metabolic active cells. Nowadays, it is assumed that TA modules
are involved in dormant persister cells formation [232]. Currently, TA systems are
assigned to five classes (I–V) according to their genetic structure and regulation
[351,485]. Increased expression of type I TA modules, such as TisB and HokE in
E. coli, has ATP synthesis cellular process as a target [485]. Although not
extensively studied, a type I TA module was already described in S. aureus [354].
Additionally, the existence of other type I TA modules in S. aureus was predicted
by bioinformatics tools, but their biological activities were not confirmed [486]. The
characterization of dormancy was also assessed by iTRAQ methodology as cross-
check validation of protein expression data, which showed main differences in
molecular functions, equivalently to label-free analysis (Figure 4.4).
Proteomic analyses of dormant cells are limited [250]. Previous proteomic studies
found a relation among GroEL (60 KDa chaperonin), DnaK (chaperone protein
DnaK), AtpD (ATP synthase subunit beta) and Eno (enolase) proteins with VBNC
bacteria, since their expression were lower [343]. Also, a decreased expression of
AhpF protein (alkyl hydroperoxide reductase subunit F), an oxidation-responsive
factor, were previously found in VBNC [487]. Our quantitative results showed that
these proteins were decreased in dormancy, however, without statistically
significant difference. Additionally, EF-Tu protein (Elongation factor Tu) was also
associated with VBNC, but results are not consistent among studies [250].
Interestingly, here, EF-Tu showed a significant increased expression in dormancy.
Similarly to transcriptomic profile of dormancy, overexpressed proteins were
related to an enrichment of ribosome synthesis pathway and structural constituent
of ribosome molecular function (Chapter 2). However, by a proteomic approach,
we did not find a significant underexpression of proteins involved in oxidation-
reduction, pyruvate metabolism and acetyl-CoA metabolic processes.
Nevertheless, we recently showed that correlation among transcripts and proteins
were not strong in S. epidermidis biofilms (Chapter 3). Thus, underexpressed
proteins were mainly associated with purine and, arginine and proline KEGG
pathways. Ion binding and catalytic activity were the main molecular functions
associated with underexpressed proteins in S. epidermidis biofilms with prevented
dormancy (Figure 4.4). Ligase, nucleotidyltransferase and hydrolase activity
combined with DNA and RNA binding, may suggest that proteins less expressed
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in S. epidermidis biofilms with prevented dormancy, are involved in transference of
nucleotidyl groups and amino acid metabolism. Moreover, hydrolase and
transferase protein classes have large number of cysteines, which are more
susceptible to oxidation [488,489]. Staphylococcus spp. use cysteine oxidation to
respond to and overcome reactive oxygen species found in the host environment
[490,491]. Oxidative stress is described as a factor that contributes to persister
cells increase [341]. However, Leszczynska et al. found that persister cells
frequency was not correlated with the oxidation of proteins [492]. Interestingly,
here we found that dormancy within S. epidermidis biofilms affected the pattern of
oxidized proteins (Figure 4.6). Among the carbonylated proteins, a few were
related to oxidoreductase activity (such as GuaB and AhpF), with RNA binding
(RpsA, EF-Tu and FusA proteins) and others were involved in ATP binding (such
as PfkA, Pgk, GroEL and DnaK). Additionally, proteins involved in response to
stress, DnaK and AhpF, were found carbonylated. Interestingly, among the
carbonylated proteins, only EF-Tu, GpmI and Pgk showed significant differences
in protein expression between prevented and induced dormancy. Our results
suggest that Pgk protein is more active in biofilms with prevented dormancy, but
may be more susceptible to oxidation and may suffer biological modifications.
However, future work in protein oxidation exploration may help to unravel if
oxidation susceptibility may contribute as a factor that leads to dormancy.
It is known that magnesium is involved in several biological processes in bacteria,
such as genomic stability, membrane stabilization and cofactor in several
enzymatic reactions [305]. Consistent with this fact, we found that proteins which
formed a closer cluster with magnesium, presented mainly nucleic acid binding
function (Figure 4.5). Interestingly, cytoplasmic membrane proteins were also
found associated with magnesium action. Dunne et al. were the first to
demonstrate the magnesium action over S. epidermidis adhesion [281]. Earlier,
Cutinelli and Galdiero aimed to describe the binding capacity of Mg2+, among other
ions, to S. aureus cell wall [291]. They proposed that high pH values increased the
amount of Mg2+ bound to cell wall. Since it was shown that pH does not vary
between the two growth conditions [406], this statement cannot explain the Mg2+
binding in the present model. Similarly, Mg2+ affinity to Bacillus subtilis cell wall
was influenced by the presence of functional groups in the peptidoglycan matrix
CHAPTER 4.
Biomedical Sciences PhD 86
[493]. In addition, Piddington et al. demonstrated that Mg2+ is essential to M.
tuberculosis growth in acidic conditions and it could not be replaced by other
divalent cations [409]. Also, a possible influence of Mg2+ in protein structure and
physical properties was also described in M. tuberculosis [410]. Recently, it was
shown that catheters coated with magnesium fluoride nanoparticles presented a
significantly reduction of S. aureus and E. coli colonization [494]. However, the
Mg2+ effect in biofilm maturation and its role on dormancy remains poorly
understood [302,409].
To the best of our knowledge, the present study represents the ﬁrst attempt to
determine protein expression differences associated to dormancy within biofilms.
For the first time, quantitative proteomics was performed in order to assess
dormancy within S. epidermidis biofilms. Label-free and label-based methods
afforded similar and relevant biological data of dormancy physiological state.
Overexpressed proteins were mainly related to ribosome synthesis pathways.
Conversely, based on the biofilm dormancy model, ion binding and catalytic
activity molecular functions seem to be related to the absence of magnesium
enrichment, which contribute to dormancy entrance. It should also be emphasized
that the output of the different quantitative strategies here employed, contributed to
a further exploration of dormant physiological condition.
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AN IMMUNOPROTEOMIC APPROACH FOR CHARACTERIZATION OF
DORMANCY WITHIN S. EPIDERMIDIS BIOFILMS
Summary
Physiological heterogeneity of biofilms may influence host immune response and
sensitivity to antibiotics. The aim of this study was to identify immunogenic
proteins of S. epidermidis biofilms associated with dormancy mechanism, by using
2-DE immunoblotting and MS. A total of 19 bacterial proteins, recognized by
human serum samples, were identified. These proteins were mainly involved in
small molecule metabolic biological processes. Catalytic activity and ion binding
were the most representative molecular functions. CodY and GpmA proteins were
more reactive to sera when biofilm dormancy was induced, while FtnA and ClpP
were more reactive when dormancy was prevented. This is the first work that
identifies differences in immunoreactive proteins within bacterial biofilms with
induced or prevented dormancy. Considering the importance of dormancy within
biofilms, further evaluation of these proteins can provide insights into the
mechanisms related to dormancy and help to improve current understanding on
how dormancy affects the host immune response.
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5.1. Introduction
Nowadays, proteomic approaches are contributing to elucidate the immunological
response to microorganisms [495]. Immunoproteomics allows the identification of
immunogenic and immunoreactive proteins that may participate in host-pathogen
interactions and in host immune response [174,496,497]. Furthermore,
immunoproteome analysis improves the understanding of pathogenesis and
unravel novel therapeutics targets based on the repertoire of immunogens [498].
Thus, plasma is one of the most relevant environmental factors in indwelling
medical devices-related infections [499]. A few aspects of immune reaction to S.
epidermidis infections were already elucidated [140,142,143,156,175,500]. By
using serum from rabbits immunized with live S. epidermidis, or serum proteins
eluted from the surface of bacteria grown in rabbit serum reactive against bacterial
cell-surface extracts, immunogenic and serum binding proteins were identified by
Western blotting [142]. Sellman et al. found 5 antigenic components candidates for
the development of S. epidermidis vaccine, namely, acetyl-coenzyme A
acetyltransferase (YqiL), Na+/H+ antiporter (SE1873), lipoate ligase (SE0360),
cysteine synthase (CysK), and alanine dehydrogenase (Ald). Also, Pourmand et
al. identified autolysin AtlE, lipase GehD and surface protein ScaB antigenic
components with therapeutic potential since they had opsonic activity in vitro [175].
To determine the immunoproteomic pattern of S. epidermidis biofilms with
prevented and induced dormancy, we resolved whole cell lysate by 2-DE and
performed immunoblotting with human sera. We then identified the
immunoreactive protein spots by MALDI-TOF/TOF. With this work we intend to
define the reactive protein repertoire of S. epidermidis biofilms with different
proportions of dormant bacteria to human serum and contribute to decipher the
host immune differences to dormancy.
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5.2. Materials and methods
5.2.1. Growth conditions
Growth culture condition was performed as previously described [138]. S.
epidermidis strain 9142 (isolated from blood culture [501]) was used to establish
biofilms with induced and prevented dormancy. Briefly, one colony of S.
epidermidis was inoculated in TSB (LiofilChem) and incubated at 37 ºC in an
orbital shaker at 120 rpm for 18 h. The overnight culture was adjusted to an optical
density at 640 nm of 0.250 (±0.05) and 10 µL of the suspension was transferred
into a 24-well plate (Orange Scientific) containing 1 mL of TSB supplemented with
0.4% glucose (v/v) (Fisher Scientific) or TSB 0.4%G enriched with 20 mM
magnesium chloride (MgCl2) (Merck). The culture plates were then incubated at 37
ºC in an orbital shaker at 120 rpm for 24 h. After this period, the culture medium
was removed and replaced by fresh TSB supplemented with 1% glucose (v/v) or
TSB 1%G containing 20 mM MgCl2 (1%G + Mg2+). Biofilms were then allowed to
grow in the same conditions for an additional 24 h. Next, biofilm culture medium
was removed and biofilms were washed twice with PBS. Then, bacteria within the
biofilms were resuspended in 1 mL of PBS. As previously described, biofilm
dormancy was determined using the spread plate method in TSA (LiofilChem)
through calculation of the number of CFU/mL in each biofilm growth condition
[138]. A reduction of about one log difference is typically expected in similarly
grown biofilms without Mg2+ [138].
5.2.2. Preparation of protein extracts
Total protein extraction was performed from multiple biofilm replicates, as
described in Chapter 4.
5.2.3. Two-dimensional electrophoresis (2-DE)
A total of 80 µg of protein was resuspended in rehydration sample buffer (8 M
urea, 2 M thiourea, 1% CHAPS, 12 mM DTT, 0.5% IPG buffer). Then, IPG 3–10
non-linear strips, 7 cm, (ImmobilineTM pH Gradient, GE Healthcare) were in-gel
rehydrated overnight for the ﬁrst dimension isoelectric focusing (IEF), performed
on a horizontal EttanTM IPGPhor (Amersham Biosciences). Isoelectric separation
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was performed using the following focusing program: 12 h at 50 mW (rehydration),
1 h at 150 V (gradient), 1 h at 500 V (gradient), 1 h at 1000 V (gradient) and 90
min at 5000 V (“step-and-hold”). After IEF, IPG strips were equilibrated with
equilibration buffer (2% (w/v) SDS, 6 M urea, 30% glycerol, 0.05 M Tris–HCl pH
8.8 and 20 mg/ml DTT) for 30 min at room temperature. Strips were then placed
on the top of a 12% SDS-PAGE gel for the second dimension separation and ran
at a constant voltage. Gels were stained with colloidal Coomassie G-250 or gels
were transferred onto a nitrocellulose membrane. Proteins were blotted on a
nitrocellulose membrane (Whatman®, Protan) in transfer buffer (25 mM Tris, 192
mM glycine, pH 8.3 and 20% methanol) during 2 h at 200 mA. Stained gels were
analyzed by using Melanie analysis software v.7.0 (GeneBio). Protein separations
by 2-DE was carried out three independent times. The signal intensities of proteins
spots were compared among both conditions and scored by fold-change.
5.2.4. Immunoblotting
Sera samples were obtained from three volunteers after informed consent was
obtained. The experiment was approved by the Ethics Committee of Instituto
Ciências Biomédicas Abel Salazar (document number 081/2014).
Nitrocellulose membranes were blocked in 5% BSA (Sigma-Aldrich) in TBS-T
(Tris-Buffered Saline-Tween 20) for 2 h. Then, membranes were incubated with
human serum (1:200) for 2 h at room temperature. Following this incubation,
membranes were washed with TBS-T for 10 min. Membrane washing step was
repeated three times. Membranes were incubated with a secondary anti-human
Imunoglobulin G (IgG, A0170, Sigma-Aldrich) (1:1000) during 1 h at room
temperature. After washing the membranes, immunodetection was performed with
enhanced chemiluminescence ECL (Amersham Pharmacia Biotech) according to
the manufacturer's procedure and the images were recorded using X-ray ﬁlms (GE
Healthcare). The films and the gels were scanned in Molecular Imager Gel Doc
XR+System (Bio-Rad) and analyzed with QuantityOne software (v. 4.6.9 Bio-Rad).
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5.2.5. In-gel protein digestion and protein identification by mass
spectrometry
Reactive protein spots were selected and manually excised from stained gels. An
in-gel digestion of gel spots, with trypsin TPCK treated (ABSciex), was performed.
Briefly, peptides extraction was made with 10% formic acid/ACN. Dried peptides
were dissolved in 5% ACN (VWR), 0.1% formic acid (Fluka Analytical, Sigma-
Aldrich) and 0.1% TFA (Sigma-Aldrich). Peptides were directly deposited onto
384-well MALDI plates (Applied Biosystems) with α -CHCA matrix solution. α-
CHCA matrix solution was prepared by diluting 2.5 mg/mL of α-CHCA in ACN
70%/TFA 0.3%. Experiments were carried out in technical duplicates. Mass
spectra were obtained on a matrix assisted laser desorption/ionization–time of
flight MALDI-TOF/TOF mass spectrometer (4800 Proteomics Analyzer, Applied
Biosystems) in the positive ion reflector mode and obtained in the mass range
from 700-4500 Da with 900 laser shots. A fragmentation voltage of 2 kV was used
throughout the automated runs. The spectra were processed and analyzed by the
Global Protein Server (GPS) Workstation (Applied Biosystems). Searches were
performed against the SwissProt (release date 06.02.2013) protein database for
Firmicutes. The database search parameters were: mass tolerance of 40 ppm for
precursor ions and 0.4 Da for fragment ions; trypsin digestion with two missed
cleavages. Protein identity was accepted at the 95% confidence level.
5.2.6. Bioinformatic analyses
GO [385] and KEGG pathway [386] analysis were performed to determine the
function of identified proteins, using STRING (version 9.1) (at 28.11.2014) [387].
Cellular localization of proteins was predicted or identified by PSORTb program
v.3.0.2 [396] and by Cello v.2.5 [502]. Immunoreactive proteins were query in
ABCPred  to predict B cells epitopes in silico [503].
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5.3. Results and discussion
Bioﬁlm formation is considered the major virulence factor of S. epidermidis [5]. It
has been described that bacteria antigen profile is affected by the mode of
bacterial growth [504], such as planktonic or biofilm cells, which may have
potentially meaningful implications in host recognition and consequent immune
response.
Figure 5.1.: Immunoblotting profile of whole proteins of S. epidermidis biofilms with induced and
prevented dormancy. The immunoblotting analysis was performed with different human sera. A)
donor 1, B) donor 2, C) donor 3. Protein spot identification is mentioned in Table 5.1.
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Here, to identify the repertoire of immunoreactive proteins in dormant condition,
we characterized the immunoproteome of S. epidermidis biofilms with induced and
prevented dormancy, using human serum as a probe. Analysis of the 2-DE
separation of whole biofilm cell protein extract from both conditions showed more
than 120 protein spots in induced and prevented dormancy. A 2.0 fold-change
protein intensity was set as a significant threshold between the two conditions.
Apparently, up to 5 spots in each experiment had a fold-change higher than 2.0.
The employment of 2-DE methodology in immunoproteomic studies is a powerful
tool to identify antigens when combined with Western blotting [495]. Interestingly,
a distinct immunoreactive protein profile of S. epidermidis biofilms with prevented
and induced dormancy was found in all tested sera (Figure 5.1). Our results
showed a total of 19 immunoreactive protein spots identified by MALDI-TOF/TOF
(Table 5.1). Most of the immunoreactive proteins spots were located in the pH
range of 4–5 and in the molecular weight range of 20–40 KDa (Table 5.1).
Only GpmI and FusA proteins were reactive to all tested sera, independently of
biofilm dormancy. Both are related to ion binding molecular function, but no more
evident connections are known, since GpmI is associated with glycolysis and FusA
with protein biosynthesis. On the other hand, GpmA protein seemed to be more
immunoreactive in induced dormancy, in all tested sera. Other proteins, such as
Pgk, TpiA and Ald, were recognized by only one serum sample. The reactive
pattern diversity found among sera samples may be due to differences on immune
response of donors or previous exposure to S. epidermidis, since it is a
commensal microorganism of skin and mucosae [1]. Interestingly, the immunoblot
pattern included a set of reactive proteins which seemed to be only
immunoreactive in biofilms with induced dormancy, such as CodY and GpmA.
Conversely, FtnA and ClpP proteins were reactive in biofilms with prevented
dormancy condition. Interestingly, CodY is a GTP-binding protein which responds
to GTP and senses nutrient availability, controlling the expression of genes
involved in the biosynthesis and transport of amino acids in several Gram-positive
species [482], such as the regulation of TCA cycle activity [505]. Typically, CodY is
repressed during rapid growth and induced when cells experience nutrient
deprivation [482], which may be related with dormancy.
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Table 5.1.: Immunoreactive proteins identified by 2-DE-MALDI-TOF/TOF.
Spot Protein AcessionNumber Protein name
MW
(KDa) pI Function
PSORTb
localization
Cello
localization
Number
of
epitopes
1 FtnA Q5HN41 Ferritin 19.58 4.55 Iron-storage protein Cytoplasmic Cytoplasmic 7
2 ClpP Q5HQW0
ATP-dependent Clp
protease proteolytic
subunit
21.38 5
Cleaves peptides in various
proteins in a process that requires
ATP hydrolysis. Has a
chymotrypsin-like activity. Plays a
major role in the degradation of
misfolded proteins
Cytoplasmic Cytoplasmic 7
3 Pgk Q5HQV3 Phosphoglyceratekinase 42.74 4.76
Catalyzes the transference of a
phosphate group from 3-phospho-
D-glycerate to ADP
Cytoplasmic Cytoplasmic 14
4 SsaA Q5HLV2
Staphylococcal
secretory antigen
SsaA
27.91 8.4
Not known; immunogenic protein
expressed during sepsis and
particularly during episodes of
infective endocarditis
Extracellular Extracellular 16
5 EF-Tu Q5HRK4 Elongation factor Tu 43.16 4.7
This protein promotes the GTP-
dependent binding of aminoacyl-
tRNA to the A-site of ribosomes
during protein biosynthesis
Cytoplasmic Cytoplasmic 22
6 Fda Q5HL21
Fructose-
bisphosphate
aldolase class 1
32.99 4.89
Glycolytic enzyme that catalyses
D-fructose 1,6-bisphosphate into
glycerone phosphate and D-
glyceraldehyde 3-phosphate
Unknown Cytoplasmic 8
7 TpiA Q5HQV2 Triosephosphateisomerase 27.37 4.9
Catalyses the interconversion of D-
glyceraldehyde 3-phosphate and
glycerone phosphate
Cytoplasmic Cytoplasmic 13
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8 GpmA Q5HLI0
2,3-
bisphosphoglycerate-
dependent
phosphoglycerate
mutase
26.7 6.46
Catalyzes the interconversion of 2-
phosphoglycerate and 3-
phosphoglycerate
Cytoplasmic Cytoplasmic 10
9 CodY Q5HPT7
GTP-sensing
transcriptional
pleiotropic repressor
CodY
28.75 5.61
It is a GTP-binding protein that
senses the intracellular GTP
concentration as an indicator of
nutritional limitations. At low GTP
concentration it no longer binds
GTP and stop to act as a
transcriptional repressor
Cytoplasmic Cytoplasmic 15
10 Ldh Q5HL31 L-lactatedehydrogenase 34.1 4.93
Catalyzes the reduction of
pyruvate into lactate Cytoplasmic Cytoplasmic 9
11 GpmI Q5HQV1
2,3-
bisphosphoglycerate-
independent
phosphoglycerate
mutase
56.36 4.8
Catalyzes the interconversion of 2-
phosphoglycerate and 3-
phosphoglycerate
Cytoplasmic Cytoplasmic 18
12 FusA Q5HRK5 Elongation factor G 76.88 4.8
This protein promotes the GTP-
dependent translocation of the
nascent protein chain from the A-
site to the P-site of the ribosome
Cytoplasmic Cytoplasmic 34
13 DnaK Q5HNW6 Chaperone proteinDnaK 66.15 4.57 Acts as a chaperone Cytoplasmic Cytoplasmic 28
14 GroEL Q5HMZ1 60 kDa chaperonin 57.75 4.59
Prevents misfolding and promotes
the refolding and proper assembly
of unfolded polypeptides generated
under stress conditions
Cytoplasmic Cytoplasmic 26
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15 ButA Q5HKG6 Diacetyl reductase[(S)-acetoin forming] 27.91 4.66
Catalyzes the irreversible reduction
of 2,3-butanediol to (S)-acetoin in
the presence of NADH
Cytoplasmic Cytoplasmic 12
16 PfkA Q5HNK6 6-phosphofructokinase 34.88 5.34
Catalyzes the reaction of D-
fructose 6-phosphate into D-
fructose 1,6-bisphosphate
Cytoplasmic Cytoplasmic 12
17 Asp23 Q5HM47 Alkaline shock protein23 19 4.92
May play a key role in alkaline pH
tolerance Unknown Cytoplasmic 7
18 Ald Q5HNJ6 Alaninedehydrogenase 40.2 5.03
May play a role in cell wall
synthesis as L-alanine is an
important constituent of the
peptidoglycan layer
Cytoplasmic Cytoplasmic 14
19 RpsA Q5HP69 30S ribosomal proteinS1 43.37 4.46
Binds mRNA; thus facilitating
recognition of the initiation point. It
is needed to translate mRNA with
a short Shine-Dalgarno (SD)
purine-rich sequence
Cytoplasmic Cytoplasmic 15
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Despite no direct involvement with dormancy has been previously described [319],
genes encoding proteins here identified, have been linked to particular
circumstances in biofilms. For example, the expression of ftnA was affected by the
presence of iron and manganese ions in the biofilm growth conditions [506]. Also,
the deletion of clpP was associated with a reduced ability to form S. epidermidis
biofilms and with reduced virulence in a rat model of bioﬁlm-associated infection
[507]. Interestingly, among the immunoreactive proteins, 3 had previously been
reported to be immunoreactive with sera from rabbits infected with live S.
epidermidis [142], namely EF-Tu, Fda and Ald. Additionally, surface proteins are
known to be crucial determinants for host colonization [508], such as SsaA, which
is a well-known immunogenic protein [509]. Similarly, in Chlamydia trachomatis,
proteins like DnaK, EF-Tu, GroEL and RpsA were also immunoreactive [510].
Since EF-Tu, DnaK and GroEL are highly conserved genes [511], they are
frequently found as immunogens in several species [510,512-514]. Additionally,
EF-Tu, DnaK and GroEL are among the proteins here identified, with a higher
number of antigenic determinants to B-cell [515] (Table 5.1), which may be the
reason for been highly reactive.
The three most representative classes of the identified proteins for biological
processes, molecular functions and KEGG pathways are shown in Figure 5.2. The
immunogenic proteins represented a broad range of biological functions, including
small molecule metabolic process (GO:0044281), catabolic processes
(GO:0009056), carbohydrate metabolic processes (GO:0005975), generation of
precursor metabolites and energy (GO:0006091) and biosynthetic processes (GO:
0009058). These proteins are mainly involved in metabolic pathways, such as
glycolysis/gluconeogenesis, microbial metabolism in diverse environments,
biosynthesis of secondary metabolites, fructose and mannose metabolism and
methane metabolism. The main molecular functions found were related to catalytic
activity (GO:0003824), ion binding (GO:0043167) and oxidoreductase activity
(GO:0016491). Bioinformatic analysis were used to predict subcellular localization
of proteins. Results showed one protein with extracellular localization. Remaining
proteins were predicted to have cytoplasmic localization (Table 5.1). These results
suggest that ion binding function may influence the host immune response, since
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previously, we identified this class of proteins with altered expression between S.
epidermidis biofilms with induced and prevented dormancy (Chapter 4).
Figure 5.2.: The most representative GO terms of biological processes, molecular functions and
KEGG pathways of immunoreactive proteins.
5.4. Conclusion
Taken together, our results showed that proteins from S. epidermidis biofilms with
prevented and induced dormancy had different reactivity to human serum,
providing the first evidences of dormancy impact in the human-bacteria immune
interaction. Nevertheless, differences in the reactivity pattern were mainly
observed in intracellular proteins, which can present difficult access to immune
system. Despite individual host factors, we found differences in the
immunoreactive protein pattern between S. epidermidis biofilms with different
proportion of dormant bacteria. The immunoreactive proteins made part of a
diverse group of proteins, ranging from proteins with proteolysis activity (ClpP),
through proteins involved in iron transport (FtnA), proteins associated with
glycolysis (GpmA) or proteins with transcription regulation biological function
(CodY). In general, it is most likely that immunoreactive proteins are involved in
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small molecule metabolic processes or catabolic process, with capacity to interact
with ion or charged atoms and catalytic activity.
Characterization of dormancy within biofilms using immunoproteomics provided
new insights into the protein expression that may determine S. epidermidis contact
with the host. Moreover, these proteins are promising candidates as biofilm
markers allowing the discrimination of physiological condition displayed by biofilm
bacteria and will be worth to consider in further studies.
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INFLUENCE OF DORMANCY IN BIOFILM TOLERANCE TO THE HOST
IMMUNE SYSTEM AND ANTIMICROBIAL THERAPY
Summary
The host response and biofilm susceptibility to antibiotic therapy are influenced by
bacteria physiological conditions as dormant bacteria contribute to the
recalcitrance of infections. In this work, we tested if different clinical and
commensal strains were able to go into a dormant state. Secondly, the
susceptibility of biofilm cells with prevented and induced dormancy to human
whole blood and antibiotics was assessed in a few isolates. Our preliminary results
suggest that human blood did not affect differently the survival of bacteria from S.
epidermidis biofilms with prevented and induced dormancy. However, it was
observed that rifampicin and tetracycline induced a viable but-not culturable state
in biofilm cells. Additionally, rifampicin was able to diffuse and kill bacteria within a
mature biofilm. To achieve this conclusion, it was crucial to distinctly assess the
culturability and viability of bacteria upon contact with the antibiotics. This highlight
the importance of using suitable methodologies to assess antimicrobial
susceptibility to avoid misleading interpretations.
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6.1. Introduction
Metabolic activity heterogeneity of cells within biofilms contribute to distinct
antibiotics susceptibility [101], tolerance to host immune response [184] and
relapsing infections [39].
Whole human blood has been used as an ex vivo model for studying the
pathogenesis of S. epidermidis [136,137,139,143]. Interestingly, it has been shown
that a significant percentage of cells within a S. epidermidis biofilm could survive in
whole human blood [143]. Nevertheless, the interaction between dormant bacteria
and human blood has not been studied so far.
Currently, it is accepted that bacterial metabolism influences the action of many
classes of antibiotics [516]. Most antibiotics act over active targets, killing growing
bacteria [1,131,217-221,517]. Despite its use as therapeutic agents, a few
antibiotics are known as important environmental factors that lead to persister cells
induction [201,231,239,518]. As referred in the general introduction of this thesis,
both persisters and dormant cells are recognized as highly tolerant to antibiotics
[124]. The discovery of new compounds or peptides displaying activity against S.
epidermidis biofilms has recently brought new hope to future successful treatment
of biofilms [171-173,519,520]. Most important, novel strategies to combat persister
cells are been pursued [115,521-526], since those survive even to high doses of
antibiotics [131,217,248,249].
Hence, based on the in vitro model to induce dormancy in S. epidermidis biofilms,
previously described by Cerca et al. [138], in the present work we intended: (a) to
determine if the dormancy model previously developed could be consistent using a
wide collection of clinical  and commensal S. epidermidis isolates; (b) to assess
the survival rate of S. epidermidis biofilm cells  with induced and prevented
dormancy when challenged ex vivo with human blood; (c) to assess the effect of
different classes of antibiotics on S. epidermidis biofilms with induced and
prevented dormancy. These goals were accomplished by employing
methodologies to quantify culturability and viability, such as CFU counting and flow
cytometry, respectively [284].
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6.2. Material and methods
6.2.1. Bacterial strain collection and biofilm formation
Clinical S. epidermidis strains were collected at Hospital Geral de Santo António
(Centro Hospitalar do Porto, EPE) and commensal isolates were isolated from
healthy donors from the region of Minho, as previously referred by Freitas AI [527]
and Oliveira and Cerca [528]. All volunteers gave written informed consent. This
study was approved by the Ethics Subcommission for Health and Life Sciences
(process SECVS 002/2013) of the University of Minho, Portugal and, the Ethics
Committee Board of Hospital de Santo António, Porto Hospital Centre, Portugal
(Reference 015/09: 014-DEFI/014-CES). A total of 18 clinical (PT13003, PT11001,
PT11002, PT11003, PT11004, PT12002, PT12003, PT12006, PT12007,
PT12013, PT12016, PT12019, PT12021, PT12022, PT12025, PT13001,
PT12018, PT12020) and 24 commensal (COM020A, COM022A, COM031A,
COM034A1, COM034A2, COM035A, COM036A, COM037A1, COM038A1,
COM045A, COM040A, COM042A, COM001B, COM057, COM058A, COM049A,
COM063B, COM002A, COM024A, COM023A, COM004A, COM003A, COM005A,
COM010B) S. epidermidis strains were included in this study.
Bacterial growth was performed as previously described [138]. S. epidermidis
strains were used to establish biofilms with induced (1%G) and prevented (1%G +
Mg2+) dormancy. Briefly, one colony of a given S. epidermidis strain was
inoculated in TSB (LiofilChem) and incubated at 37 ºC in an orbital shaker at 80
rpm for 18 h. The overnight culture was adjusted to an optical density at 640 nm of
0.250 (±0.05) and 10 µL of the suspension was transferred into a 24-well plate
(ThermoScientific) containing 1 mL of TSB supplemented with 0.4% glucose (v/v)
(Merck) or TSB 0.4%G enriched with 20 mM magnesium chloride (MgCl2) (Merck).
The culture plates were then incubated at 37 ºC in an orbital shaker at 80 rpm for
24 h. After this period, the culture medium was removed and replaced by fresh
TSB supplemented with 1% glucose (v/v) or TSB 1%G containing 20 mM MgCl2
(1%G + Mg2+). Biofilms were then allowed to grow in the same conditions for an
additional 24 h. Finally, biofilm culture medium was removed from each well and
washed twice with PBS. Before plating the serial dilutions of biofilm bacteria
suspension in TSA, the number of viable cells was determined by flow cytometry
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(as described below) and normalized to the same concentration of viable bacteria
between the two conditions.
6.2.2. Susceptibility to human blood
An ex vivo model was used to assess the susceptibility of S. epidermidis cells from
biofilms with prevented and induced dormancy to human blood. Whole venous
blood from different healthy donors was collected into heparin tubes by using a
vacuum system (approved by the Ethics Committee of Instituto de Ciências
Biomédicas Abel Salazar (document number 081/2014)) (BD Vacuteiner®,
Becton, Dickinson and Company), since heparin will not deplete ions that could be
essential for bacterial growth [529]. After biofilm formation, biofilm cells were
resuspended in 1 mL of PBS and the number of viable cells was determined by
flow cytometry, as referred below. In a 2 mL eppendorf, 1×107 bacteria were
added to 1 mL of blood, and incubated at 37 ºC, at 80 rpm. At every 30 min, until
120 min, an aliquot of each condition was collected and sonicated during 15 s at
18W (W185D model, MSE). The number of culturable cells was determined by
performing 10-fold serial dilutions of the biofilm suspension and plating the
dilutions on TSA plates. Plates were then incubated for 20 h at 37 °C.
Simultaneously, the number of viable cells was determined by flow cytometry. To
determine the reduction of viable or culturable cells in each timepoint, the Δlog
was calculated by subtracting the log10 bacteria/mL recovered after blood
incubation to the log10 bacteria/mL recovered at the untreated bacteria (control) of
the same timepoint. Experiments were carried out 1 to 2 times, with a pool of 4
biofilms and with blood from healthy volunteers.
6.2.3. Quantification of viable cells by flow cytometry
The number of viable cells were determined by using flow cytometry, as previously
described [284]. Briefly, 30 µL of cell suspension (after sonication) was added to
270 µL of PBS containing 5 µg/mL of PI (Sigma-Aldrich) and SYBR® Safe
(Invitrogen) diluted at 1:5000. Then, 3 µL of fluorescent counting beads
(Invitrogen) were added to allow bacteria quantification in flow cytometer
(COULTER® EPICS® XL™ Flow Cytometer, Beckman Coulter). Data were
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acquired using Expo 32 ADC XL 4 Color. SYBR fluorescence was detected on the
FL1 channel, while PI fluorescence was detected on the FL3 channel.
6.2.4. Antibiotic susceptibility of in vitro biofilms
Biofilms were prepared as described above. Biofilm culture medium was removed
from each well containing the biofilm, and replaced by 1 mL of TSB or 1 mL of
TSB with one of the studied antibiotics at the Peak Serum concentration (40, 16
and 10 µg/mL for vancomycin, tetracycline and rifampicin, respectively) [99]. Then,
biofilms were incubated at 37 ºC in an orbital shaker at 80 rpm. Every 2 h, until 8
h, biofilm culture medium was removed and biofilms were washed twice with PBS.
Then, biofilms were resuspended in 1 mL of PBS and washed twice with PBS,
followed by sonication during 15 s at 18W. The number of culturable cells was
determined by plating 10-fold serial dilutions of biofilm suspension on TSA plates,
which were incubated for 24 h at 37 °C. Simultaneously, the number of viable cells
was determined by flow cytometry. To determine the antibiotic efficacy, the
reduction of viable or culturable cells in each timepoint (Δlog) was calculated by
subtracting the log10 bacteria/mL recovered after antibiotic incubation to the log10
bacteria/mL recovered in untreated biofilm (control). This experiment was repeated
3 to 4 times, including two biological replicates in each experiment.
6.2.5. Confocal laser scanning microscopy (CLSM) of biofilms upon contact
with antibiotics
S. epidermidis biofilms formed by strain 9142 were grown as described above,
with minor modifications: the biofilms were formed on 13 mm of diameter sterile
plastic coverslips (Thermanox, Nunc) that were previously added to the 24-well
culture plates. Biofilms with induced and prevented dormancy were exposed to
tetracycline, rifampicin and vancomycin peak serum concentrations during 6 h, at
37 ºC and 80 rpm. Then, biofilms were washed twice with PBS. Biofilm cell viability
was determined with Live/Dead BacLight Bacterial Viability kit (Molecular Probes),
following the manufacturer’s instructions. Biofilms were incubated with the staining
for 15 min at room temperature, which was carefully removed by PBS. A positive
control, without incubation with antibiotics was analyzed at the same time. A
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negative control was included, by incubating the biofilm with 96% ethanol for 2 h,
as previously described [179]. Images were acquired in Confocal Scanning Laser
Microscope Olympus BX61, model FluoView1000. Biofilms were observed using a
40× water-immersion objective, in at least three different regions of two
independent surfaces and images were acquired with 640 × 640 resolution. This
experiment was repeated twice.
6.2.6. Statistical analysis
All graphs were generated using GraphPad Prism Software v.6 (GraphPad
Software). Normality was tested with Shapiro-Wilk test. When normality test was
passed, unpaired t-test was performed, assuming that both populations have the
same standard deviation. When populations did not pass the normality test, Mann-
Whitney was performed. A p value of less than 0.05 was considered statistically
significant.
6.3. Results
6.3.1. Biofilm dormancy in clinical and commensal S. epidermidis isolates
Clinical and commensal isolates were used to establish in vitro S. epidermidis
biofilms. In order to determine if these strains were able to respond in accordance
with the model previously reported in which dormancy was induced in S.
epidermidis biofilms [138], the number of viable and culturable cells were
determined. Viable cells (SYBR+PI-) within a biofilm was determined and adjusted
by flow cytometry. Then, culturable bacteria were determined by spread plate
method. The number of culturable cells/mL is shown in Figure 6.1A.
As shown in Figure 6.1A, overall, the number of culturable cells in commensal and
clinical S. epidermidis isolates resulted in lower number of CFU/mL in biofilms
grown in dormant condition (1%G), indicating that Mg2+ prevented the bacterial
entrance in dormancy. These results indicate that the dormancy effect was
observed in both groups of isolates.  However, the same degree of dormancy was
not observed in all isolates (Figure 6.1B). Of note, 4 clinical (22.2%) and 6
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commensal (25%) isolates presented less than 0.5 Log difference between
induced and prevented dormancy.
Figure 6.1.: (A) Number of culturable cells/mL of clinical and commensal S. epidermidis isolates in
TSA plates.  Each symbol corresponds to the mean of the CFUs performed in duplicate. Horizontal
bars represent the mean of the indicated group. Comparison between induced (1%G) and
prevented (1%G + Mg2+) dormancy in each group of strains was performed by using Wilcoxon test.
*p < 0.05; (B) Ratio between the number of culturable cells/mL in 1%G and 1%G + Mg2+, in
percentage. Horizontal bars represent the mean with 95% of confidence interval.
6.3.2. Biofilm cells susceptibility to human blood
Using an ex vivo model, we investigated the survival of S. epidermidis biofilm cells
upon contact with human blood. For that, we randomly selected 2 commensal and
2 clinical isolates and, incubate the same number of viable bacteria obtained from
biofilms with prevented or induced dormancy with whole human blood. The model
strain 9142 was also included in this study. Following incubation at different
timepoints, we determined the number of culturable cells by CFUs counting
(Figure 6.2).
We observed a reduction of S. epidermidis culturability up to 120 min, after
exposure to human blood, with no apparent distinction between commensal and
clinical isolates. Since this experiment was performed a limited number of times,
we cannot draw major conclusions regarding how dormancy affects survival of
biofilm cells exposed to human blood. However, based on these preliminary
results, we can suggest that no major differences were observed between induced
and prevented dormancy, and after 60 min of incubation both conditions presented
a similar decrease in bacteria culturability.
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Figure 6.2.: Mean fold reduction of cellular culturability after incubation with whole human blood.
The y-axis indicates the difference between the strain without incubation with blood and the strain
upon contact with blood, in induced dormancy (1%G) and prevented dormancy (1%G + Mg2+).
Vertical bars represent standard deviation of isolates with two independent experiments. The
remaining isolates were tested only once and do not have standard deviation.
6.3.3. Biofilm susceptibility to antibiotics
To assess the effect of dormancy in biofilms susceptibility to antibiotics, we
selected different antibiotic classes, such as the glycopeptide vancomycin (cell-
wall biosynthesis inhibitor), the rifamycin rifampicin (transcription inhibitor) and
tetracycline (protein synthesis inhibitor) [530]. The individual effect of these
antibiotics against intact S. epidermidis biofilms from different clinical and
commensal isolates was assessed. First, we determined the effect of antibiotics
over time, using the strain 9142 and up to 8 h of incubation. Figure 6.3A, 6.33C
and 6.3E show the effect of rifampicin, vancomycin and tetracycline over
culturability of S. epidermidis biofilms formed with strain 9142.
As observed, rifampicin was the most effective antibiotic acting on intact biofilms
and presented an increased action over time. Additionally, a reduction in
culturability was also observed when tetracycline was used, although with a lower
effect when compared to rifampicin. Vancomycin had no effect in cell culturability,
even after 8 h of interaction. Interestingly, significantly differences in culturability
reduction were detected in prevented and induced dormancy, when rifampicin and
tetracycline were tested.
CHAPTER 6.
Biomedical Sciences PhD 114
Figure 6.3.: Mean fold reduction of cellular culturability (A, C, E) and of cellular viability (B, D, F)
after incubation with antibiotics. The y-axis indicates the difference between the S. epidermidis
strain 9142 without incubation with antibiotics and the strain upon contact with them, in induced
dormancy (1%G) and prevented dormancy (1%G + Mg2+). This experiment was repeated four
times with independent replicates. Vertical bars represent standard deviation. * Indicates significant
differences when 1%G was compared to 1%G + Mg2+, with p < 0.05.
In order to clarify if the observed effect on culturability was caused by death or
dormancy, SYBR/PI staining was used to quantify viable cells by flow cytometry
(Figure 6.3B, 6.3D, 6.3F). These results demonstrated that the only antibiotic
which reduced S. epidermidis biofilm cell viability was rifampicin. However cell
viability reduction was significantly lower than culturability reduction. Biofilms with
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prevented dormancy showed a higher decrease in viability when treated with
rifampicin, which increased until 4 h. Interestingly, tetracycline treatment did not
lead to a reduction of viability. In agreement with culturability data, vancomycin did
not affect viability.
To confirm these results, the same S. epidermidis isolates tested in the human
blood experiments, were used. Biofilms were formed with clinical and commensal
S. epidermidis isolates and placed in contact with the antibiotics for 6 h. The
reduction of bacterial cell culturability is shown in Figure 6.4. Similar to what was
observed for strain 9142, rifampicin was the most effective antibiotic in reducing
bacterial cell culturability and vancomycin had a low effect over bacterial
culturability, in all strains tested. Interestingly, tetracycline had an increased effect
in biofilms with induced dormancy. However, the variable effect of rifampicin in
biofilms with induced or prevented dormancy, seems to be strain dependent, since
it led to a higher reduction in culturability of induced dormancy biofilms of PT13003
in opposite to COM040A and PT12016 isolates. Additionally, an analysis of the
effect on viable cell counting revealed that similarly to strain 9142, it was only
observed a reduction of viability when rifampicin was tested (Figure 6.4B, 6.4D,
6.4F). Herein, significant differences were found in COM001B and PT12016
isolates, where there was a higher reduction in viability of biofilms with prevented
dormancy (Figure 6.4D).
6.3.4. Effect of antibiotics on biofilm viability and structure
The effect of antibiotics over the biofilm structure and viability of S. epidermidis
was assessed by CLSM, using the model strain 9142 (Figure 6.5). CLSM analysis
confirmed our previous observations: among all tested antibiotics, rifampicin was
the only one that significantly changed structure and cell viability. Importantly,
CLSM images demonstrated that rifampicin was able to diffuse and kill bacteria
even in the deeper biofilm layers (Figure 6.5C and 6.5D). In the opposite, biofilms
treated with vancomycin (Figure 6.5E and 6.5F) and tetracycline (Figure 6.5G and
6.5H) contained mainly viable bacteria.
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Figure 6.4.: Mean fold reduction of cellular culturability (A, C, E) and of cellular viability (B, D, F)
after 6 hours of incubation with antibiotics of different commensal and clinical isolates. The y-axis
indicates the difference between the S. epidermidis strain without incubation with antibiotics and
the strain upon contact with them, in induced dormancy (1%G) and prevented dormancy (1%G +
Mg2+). The experiment was repeated at least three times with two independent replicates. Vertical
bars represent standard deviation. * Indicates significant differences when 1%G was compared to
1%G + Mg2+ with p < 0.05.
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6.4. Discussion
It is estimated that bioﬁlm-related infections represent between 65% (to CDC) to
80% (to NIH) of all human infections [42]. Between 30% and 50% of catheter-
related bacteremia are caused by coagulase-negative Staphylococci [16,530]. The
interest on clinical and commensal isolates ability to form biofilm and its relevance
to clinical infections is not recent [418,419,531-536]. From genome to proteome,
deep analyses have been carried out in order to find the trigger between
commensalism and pathogenicity of S. epidermidis. Using an in vitro model to
induce and prevent dormancy within S. epidermidis biofilms, we first tested if
clinical and commensal strains were able to enter into a dormant state (Figure
6.1). Our results confirmed that dormancy modulation is widespread in different S.
epidermidis isolates obtained from different sources. These results suggest that
this is indeed a relevant mechanism of S. epidermidis biofilm physiology, not
exclusive to clinical strains. However, culturable differences between biofilms with
induced and prevented dormancy tend to be lower in commensal isolates, when
compared to the tested clinical isolates. Furthermore, we were interested in
assessing how dormancy would influence the biofilm survival when exposed to
human blood. Interestingly, despite a reduction of culturability of bacteria upon
blood interaction, we did not found significant differences between clinical and
commensal isolates, neither between induced and prevented dormancy (Figure
6.2). However, due the low availability of blood donors, this experiment was
performed a limited number of times. Furthermore, taken in consideration donor-
to-donor variability inherent in human blood, conclusions from these experiments
need to be considered carefully.
Contrary to the ex vivo blood experiments, we found important differences in
antibiotics action in biofilms with induced and prevented dormancy. It is known that
biofilm tolerance to antibiotics may be associated with the existence of
subpopulations of bacteria with distinct metabolic activity that consequently
tolerate antibiotics and persist [222,403,516,537,538]. As could be expected
[179,539-541], vancomycin had a limited action against mature biofilms (Figure
6.3E, 6.3F, 6.4E, 6.4F, 6.5E, 6.5F). Interestingly, vancomycin is the recommended
treatment for methicillin-resistant S. epidermidis (MRSE) infections, despite the
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Figure 6.5.: Effect of rifampicin, vancomycin and tetracycline, after 6 hours of incubation, on biofilm
structure formed by strain 9142 with induced (1%G) and prevented (1%G + Mg2+) dormancy.
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emergence of strains with reduced susceptibility to vancomycin [542]. Contrary,
rifampicin and tetracycline led to a reduction of bacteria culturability. However,
when the number of viable cells was assessed, only rifampicin led to a reduction of
cell viability over time. These results were further confirmed by CLSM (Figure 6.5).
Most importantly, the reduction in viability upon incubation with rifampicin (~1 Log)
was not as drastically as observed for culturability (~2 - 4 Log). These results
underline that rifampicin is not primarily leading to cell death, but inducing bacteria
to go into a viable but non-culturable state in a higher extent. This observation was
further confirmed by testing further strains of S. epidermidis. On the other hand,
our data clearly suggests that tetracycline is leading biofilms to enter into a viable
but non-culturable state instead of causing bacterial death, since it was not
observed a reduction of bacteria viability (Figure 6.3A, 6.3B, Figure 6.4A, 6.4B and
Figure 6.5B, 6.5H). Flemming et al. have shown that biofilms treated with
tetracycline contained a low metabolic activity despite a significant levels of live
cells was detected by CLSM [173], which may suggest that indeed, tetracycline
was inducing a physiological state characterized by VBNC bacteria. Interestingly,
Pasquaroli et al. also demonstrated that the environmental antibiotic stress was
able to induce a VBNC state in S. aureus biofilms [201]. Curiously they
demonstrated, by epiﬂuorescence microscopy and ﬂow cytometry after Live/Dead
staining, that vancomycin promotes the emergence of persistent VBNC.
Additionally, their resuscitation studies showed that persistent VBNC forms
recover full metabolic activity and culturability in supplemented fresh medium.
Due to the clinical relevance of dormant bacteria within biofilms, an appropriate
assay should be employed to detect this sub-population of bacteria and to assess
the exact effect of antibiotics against bacteria. Most of the times, CFUs and XTT
(tetrazolium salt) assay have been used as an indicator of viability, despite limited
capacity to detect viable but non-growing bacteria. For instance, it is easily found
in the literature that rifampicin lead to a high reduction of culturability in S.
epidermidis biofilms [99,104,179,541,543,544]. However, in most cases, the
reduction in cell culturability has been directly associated to cell death.
Furthermore, methods to assess the metabolic activity reduction, also lack clear
evidence that the reduction in metabolism is, in fact, resultant of cell death
[99,173,545]. Therefore, a direct correlation between culturability, metabolic
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activity and viability is scarce [251]. More recently, techniques involving Live/Dead
fluorescence probes were introduced, being microscopy and flow cytometry
[138,201,244,284,546-548] used to determine culture viability. In parallel,
microscopy may be used to demonstrate the damage caused by the antibiotic
action. For instance, a flow-cell associated with a confocal laser scanning
microscopy were used to simulate the changing antibiotic concentrations in
humans associated with intravenous dosing on P. aeruginosa biofilms [549].
In conclusion, this study emphasizes the importance of assessing the effect of
antibiotics using appropriate methodologies that allow distinguishing culturable
and viable cells. This point represents an important drawback in published studies
that address antimicrobial effect as a measurement of cellular culturability which
can raise many doubts about the real effect of antimicrobial drugs.  Importantly,
even when not detectable, dormant cells may have significant clinical implications.
First, since dormant bacteria are not detected by traditional culture methods,
misleading interpretations about the infection status may affect the success of
therapeutic options [243]. Secondly, there is a possibility of dormant bacteria
revert the phenotype into metabolic active cells [550]. Lastly, despite the lower
inflammatory properties of dormant bacteria [138,296] they can still elicit an
inflammatory process that may affect the patient’s quality of life.
CHAPTER 7.
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7.1. Final remarks
Due to the clinical consequences of the presence of dormant bacteria within a
biofilm, an extended characterization of dormancy may contribute to underline
mechanisms of this specific microbial phenotype. More information on dormant
physiology will enable the development of strategies to obtain a successful
treatment.
Most probably, the mechanisms involving dormant cells formation are dependent
on multiple genes or pathways. This lack of knowledge depends mostly on the fact
that, direct analysis of dormant bacteria on a single cell level is not yet feasible.
Additionally, the existence of dormant bacteria within a biofilm was demonstrated
in vitro, but despite all evidences, it has been difficult to demonstrate their
presence in vivo [178,243]. It is of general knowledge that in vitro experiments
represent an important limitation, since in vitro models respond differently as
compared with in vivo bioﬁlms [176-178]. Yet, efforts have been made to develop
biofilm models which include biofilm properties such as, complexity and cellular
heterogeneity [551].
Thus, we undertook a global characterization of in vitro S. epidermidis biofilms with
prevented and induced dormancy employing an integrated analysis of different
“omics”. Transcriptomic, proteomic and immunoproteomic profile analysis were
conducted. Additionally, we were also interested in assessing the relevance of
dormancy in terms of clinical aspects, such as the ability of different isolates to
trigger dormancy and their interaction with human blood and antibiotics.
I. Which are the main transcriptomic and proteomic features of biofilm
dormancy?
Taken in consideration the whole transcriptome and proteome profile analysis of
S. epidermidis biofilms with prevented and induced dormancy, the main features
that characterizes dormancy within S. epidermidis biofilms were draw (Figure 7.1).
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Figure 7.1.: Main aspects of dormancy within S. epidermidis biofilms accomplished by
transcriptomic and proteomic approaches.
Although not surprisingly, translation process and ribosome synthesis pathways
were found decreased in dormancy. Curiously, pyruvate metabolic pathway was
enhanced in dormancy in comparison with biofilms with prevented dormancy.
Pyruvate is the product of glycolysis pathway and it is known that in the aerobic
conditions in the presence of glucose, there is an increase expression of glycolytic
enzymes. However, the role of pyruvate metabolic pathway in dormancy was not
further investigated. Additionally, proteins with GTPase activity seems to be
increase in a magnesium limited environment. Given the high number of
transcripts and proteins of S. epidermidis, the comparison of the transcriptome and
proteome is extremely complex and may lead to misinterpretations. More
specifically, proteins which could play a role in the dormancy process may be less
frequent and in lower concentration [552]. Nevertheless, it is worth noting that the
global changes found in biofilms with induced dormancy refer to the bulk of biofilm
cells and not only to dormant bacteria.
II. Is there a correlation between transcriptomic and proteomic data?
Despite the correlation between transcriptomic and proteomic data from S.
epidermidis biofilms was shown to be low, it was possible to identify common
features between both approaches (Figure 7.1). These were expected results
since the correlation between transcriptome and proteome expression has been
assumed to be low in bacteria [432]. Nevertheless, comparative analysis in
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biofilms may be neglecting the importance of post-translational modifications
(PTMs) since it was reported that: (a) phosphorylation  seems to play a key role in
biofilm development steps [553]; (b) an increase in the number of Ser/Thr-
phosphorylated proteins seems to be important in nutrient-induced bacteria
dispersion [554]; (c) and glycosylation may be a key signaling for host-bacteria
interaction correlated with bacteria pathogenicity [555].
III. Are there any differences between immunoproteomic profile of
induced and prevented biofilm dormancy?
Since the bacterial biofilm colonization is a complex interplay between the
bacteria, the host and the biomaterial, the interest on how the biofilm interact with
the host could reveal important aspects associated to the immune evasion. The
most remarkable feature of immunoproteomic profile between both conditions was
the observation that CodY protein could be more reactive to human sera when
dormancy was induced, and ClpP protein when dormancy was prevented.
Nevertheless, the expression of CodY is increased when cells experience nutrient
deprivation, suggesting that magnesium is an important nutrient in in vitro S.
epidermidis biofilms. More importantly, ClpP protein cleaves peptides in the
presence of ATP and magnesium and it is associated with virulence of a biofilm-
associated infection. In fact, S. epidermidis biofilms with prevented dormancy were
previously linked to a higher inflammatory profile [138,296].
IV. What’s the clinical relevance of dormancy?
Lastly, dormancy was observed in the majority of clinical and commensal strains of
our bacteria collection (n = 43). It is worth to note that the survival of bacteria from
biofilms with prevented and induced dormancy did not seem to be distinctly
affected upon contact with whole human blood. The most interesting new finding
was related to the effect of antibiotics, such as tetracycline and rifampicin, against
S. epidermidis biofilms. Curiously, both antibiotics are inducing biofilm cells to
enter in a VBNC state. In order to achieve these new findings, it was determinant
to assess the culturabilty and viability of bacteria upon contact with antimicrobials.
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7.2. Future perspectives
The described work highlighted several aspects regarding S. epidermidis biofilms
with induced and prevented dormancy. However, several questions remain open
and may be taken in consideration in the near future.
First, as mentioned above, we would like to identify the contribution of ClpP and
CodY to the dormant mechanism and understand if they constitute important
markers related to dormancy and inflammatory properties of a biofilm infection.
Furthermore, all proteins found reactive to human sera should be considered for
additional studies since they are promising candidates as biofilm markers and
also, as potential preventive or therapeutic targets.
Second, antibiotics caused a decrease of culturable cells without reduction of
viability. However, we can not distinguish these cells of being persister or VBNC or
dormant bacteria. Therefore, further experiments are needed to overcome this
limitation, despite the difficulty to differentiate between the resuscitation of VBNC
cells and the normal growth of residual culturable cells in the remaining sample.
Third, bacteria behavior is influenced by the interaction with the host. In order to
minimize this disadvantage in our future investigations, we should include a host
component that contributes to mimic the host conditions. However, heterogeneity
among individual donors’ will imply a higher number of independent experiments
to be performed.
Fourth, it would be of upmost importance to identify the role of magnesium during
the development of our model, in in vivo conditions. Recently, implants with
magnesium were tested for in vitro and in vivo antibacterial properties against S.
aureus [556,557]. These studies revealed that the magnesium implant reduced
bacterial adhesion, prevented the implant contamination and led to a faster new
bone tissues formation, indicating that the degradation of magnesium could also
promote the osteogenic process with good biocompatibility.
Lastly, detection and analysis of post-translational modifications, such as
phosphorylation and glycosylation, may be considered to understand bacterial
pathogenicity.
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